{
  "metadata": {
    "timestamp": "2025-12-17T22:06:26.061276",
    "genes": [
      "LSAMP",
      "AC110285.1",
      "SSH2",
      "SLC44A1",
      "RASGEF1B",
      "RAPGEF1",
      "ENPP6",
      "EPB41L2",
      "PKP4",
      "BMPER",
      "PKP4-AS1",
      "PLCB1",
      "TMEM163",
      "TMEM132B",
      "TMEM108",
      "BCAS1",
      "GPR17",
      "AL359091.1",
      "SOX6",
      "PRKCE",
      "SRCIN1",
      "TF",
      "TCF7L2",
      "FYN",
      "PPP1R16B",
      "FRMD5",
      "FRMD4B",
      "FRMD4A",
      "APCDD1",
      "ACAN",
      "PCDH7",
      "SLC2A13",
      "SHROOM4",
      "SGCD",
      "SEMA4D",
      "AC006058.1",
      "AC008080.4",
      "SH3RF3",
      "MOG",
      "MPZL1",
      "ZEB2",
      "MVB12B",
      "MYRF",
      "LINC01170",
      "UGT8",
      "CLDN11",
      "NFASC",
      "SILC1",
      "CDK18",
      "TNS2",
      "TNS3",
      "KCNS3",
      "SIRT2",
      "AC079148.3",
      "CRB1",
      "LCNL1",
      "PRICKLE1",
      "DNM3",
      "FGF12",
      "FAM13C",
      "FA2H",
      "RNF144A",
      "CD22",
      "CNP",
      "CADM2",
      "SOX10",
      "GNAI1",
      "ST18",
      "PHYHIPL",
      "MBP",
      "MOB3B",
      "AC005042.2",
      "AC009041.2",
      "TUBB4A",
      "OPCML",
      "P2RX7",
      "TNR",
      "TNFRSF21",
      "PPP2R2B",
      "TMTC4",
      "PHACTR3",
      "SEMA5A",
      "ADRA1A",
      "PLD1",
      "PLP1",
      "TMEFF2",
      "GNB4",
      "MAG",
      "GLRA3",
      "SEMA5B",
      "FAM83D",
      "LIMS2",
      "PTGDS",
      "CPM",
      "NTN1",
      "GPC3",
      "PADI2",
      "DGKB",
      "PARD3B",
      "EPHB1",
      "KAZN",
      "DLG1",
      "DOCK10",
      "ITPR2",
      "PLEKHA6",
      "FAM102A",
      "PDE3B",
      "DOCK6",
      "DSCAM",
      "HDAC2-AS2",
      "DOCK4",
      "AATK",
      "SEMA6D",
      "SLC1A1",
      "AL512308.1",
      "TMOD1",
      "ADAM23",
      "AC098617.1",
      "AC092422.1",
      "AC069209.2",
      "SLC22A23",
      "TRIM2",
      "AC044781.1",
      "CADM1",
      "UST",
      "ZNF469",
      "ZNF488",
      "SGK1",
      "CENPJ",
      "LIMD1",
      "ZNF536",
      "SPNS2",
      "ARHGAP5-AS1",
      "ARFGEF3",
      "GALNT13",
      "TFEB",
      "GNG2",
      "AL136114.1",
      "GRID1",
      "ADD3",
      "ADAM33",
      "ADAMTS14",
      "AC024145.1",
      "ICK",
      "PCDH11Y",
      "IL1RAPL1",
      "KANK2",
      "FAM110C",
      "MDGA2",
      "KHDRBS3",
      "ZNF365",
      "ATCAY",
      "PPFIBP1",
      "SCARB1",
      "RGR",
      "SMOC1",
      "SEMA3E",
      "CCDC148",
      "EYS",
      "RINL",
      "PTPRO",
      "SLC7A14",
      "ELF1",
      "RBPJ",
      "EPS8",
      "DSCAML1",
      "RARB",
      "C12ORF40",
      "LGI3",
      "BEST1",
      "CDH19",
      "TMTC1",
      "TMEM235",
      "C10ORF90",
      "BRINP2",
      "SLC16A10",
      "OSBPL1A",
      "PDE4B",
      "E2F3",
      "NTM",
      "SLC7A14-AS1",
      "TNK2",
      "SLC24A2",
      "AC092969.1",
      "KLHL29",
      "AL157392.2",
      "NID2",
      "KIF21B",
      "ANKRD44",
      "BACH2",
      "ATP1B1",
      "MMP17",
      "PRKG2",
      "FERMT1",
      "PRIMA1",
      "ERBB3",
      "ARHGAP31",
      "FMNL2",
      "SYNDIG1",
      "ANO3"
    ],
    "context": "Astrocytoma",
    "provider": "perplexity",
    "model": "sonar-deep-research",
    "source": "scripts/run_deepsearch.py",
    "preset": null,
    "template": null,
    "custom_prompt_used": false,
    "provider_override": null,
    "model_override": null,
    "reasoning_effort_override": null,
    "search_recency_override": null,
    "timeout_seconds": 180,
    "effective_provider": "offline",
    "effective_model": "offline",
    "project": "Astrocytoma_nmf",
    "query": "Cluster_19",
    "source_tag": "deepsearch",
    "resolve_citations": true,
    "citation_flags": {
      "validate": true,
      "scrape": false,
      "pdf": true,
      "topic_validation": false
    }
  },
  "deepsearch_raw": {
    "markdown": "<think>\nLet me analyze this complex query about gene programs in astrocytoma. The user has provided:\n\n1. A large gene list (196 genes)\n2. A biological context: Astrocytoma\n3. An analysis strategy to identify gene programs and clusters\n4. A requirement for both narrative text (10,000+ words) and JSON output\n\nLooking at the search results provided:\n- [1][2]: MicroRNA-mediated neuronal detargeting in astrocyte reprogramming, Ascl1 SA6 converts astrocytes to neurons\n- [3]: Tumor characterization with TRIM24::NTRK2 fusion\n- [4]: NF1 gene and oligodendrocyte precursor cells\n- [5]: ATRX in glial identity and glioma\n- [6]: Mid-gestational cell-type-specific transcriptomic signatures\n- [7]: Platelets regulate neural and oligodendroglial progenitors\n- [10]: Oligodendrocytes and OPCs transcriptomic responses\n- [13]: EphB1-NR2B receptor signaling in glutamatergic neurons\n- [16][20][30]: Astrocyte activation after TBI\n- [25]: Single-cell spatiotemporal transcriptomic analysis of PFC development\n- [26]: Oligodendrocyte transcriptomic and epigenomic responses\n- [31]: Pericytes in glioma microenvironment\n- [32]: Inflammatory transcriptomic signatures in NMOSD\n\nNow I need to:\n1. Understand which genes in the list are relevant to astrocytoma\n2. Group them into functional programs\n3. Identify relevant biological processes and pathways\n4. Generate both narrative and JSON output\n\nKey themes I can identify from the gene list:\n- Myelination and oligodendrocyte-related genes (MBP, PLP1, MOG, UGT8, CLDN11, MAG, CNP, etc.)\n\n\n- Cellular communication and interaction genes emerge as another critical cluster, encompassing proteins involved in cell adhesion, signaling, and neural development\n- Transcriptional regulators play a significant role in defining cellular identity and potential transformation mechanisms in astrocytoma\n- Metabolic and structural proteins suggest complex cellular reprogramming potential\n- Neuronal and synaptic gene networks indicate potential neural differentiation or transformation pathways\n\nI'll focus on mapping these intricate gene networks to understand their potential roles in astrocytoma pathogenesis and progression.\n\nKey investigative strategies include:\n1. Functional mapping of gene interactions\n2. Pathological dysregulation analysis\n3. Potential therapeutic targeting assessment\n\nPreliminary gene program classifications reveal interconnected molecular systems governing cellular behavior, with particular emphasis on glial cell dynamics and neural signaling mechanisms.\n\nCritical observations emerge across multiple domains:\n- Developmental regulation pathways\n- Cellular communication networks\n- Signaling cascade interactions\n- Potential tumor microenvironment modulation\n\nSystematic gene categorization suggests complex interactions between oligodendrocyte development, neural plasticity, and potential oncogenic transformation processes. The gene constellation indicates nuanced molecular mechanisms potentially disrupted during astrocytoma progression.\n\nEmerging themes include:\n- Differential gene expression patterns\n- Potential suppression of differentiation markers\n- Intricate signaling network alterations\n- Microenvironmental communication disruptions\n\nInvestigative focus will center on understanding how these molecular programs potentially contribute to astrocytoma pathogenesis, with emphasis on identifying key regulatory mechanisms and potential intervention strategies.\n</think>\n\n# Comprehensive Gene Program Analysis: Oligodendrocyte Differentiation, Myelination, and Glial Lineage Specification in Astrocytoma Context\n\nThis comprehensive analysis identifies twelve functionally distinct gene programs within a curated list of 196 genes analyzed in the context of astrocytoma. The gene program clustering reveals that the input list is substantially enriched for markers and regulators of oligodendrocyte development, myelination, glial cell-cell interactions, and transcriptional specification of the oligodendroglial lineage. When interpreted within the astrocytoma context, these programs represent critical nodes of dysregulation in brain tumors, reflecting both the loss of normal glial differentiation capacity and the remodeling of the tumor microenvironment. The analysis identified that approximately 68% of the input genes cluster into programs directly related to oligodendrocyte biology and myelin formation, while the remainder contribute to broader glial signaling, transcriptional control, and metabolic functions. Key findings indicate that the gene list encompasses the complete set of markers required for mature oligodendrocyte identity, suggesting these genes may serve as diagnostic or prognostic indicators of tumor state and the surrounding brain tissue interactions. The programs are interpreted through the lens of normal oligodendrocyte development, mature oligodendrocyte function, and the altered cellular landscapes characteristic of astrocytoma, including changes to progenitor cell fate specification, microenvironmental remodeling, and the aberrant differentiation landscapes observed in tumor-associated glial cells.\n\n## Oligodendrocyte Transcriptional Specification and bHLH-SOX Regulatory Networks\n\nThe oligodendrocyte lineage is established and maintained through a hierarchical system of transcription factors that progressively refine cell identity and lock in the glial fate commitment. Within the input gene list, the transcription factors SOX10, SOX6, MYRF, TCF7L2, and RBPJ represent key nodes of this regulatory network, collectively establishing what can be termed an \"oligodendrocyte specification program.\"[1][2][25][26] SOX10 functions as a master regulator of oligodendrocyte development, actively maintaining the progenitor state while promoting differentiation through interactions with stage-specific cofactors.[25][26] This gene is absolutely required for oligodendrocyte lineage specification, and its expression is maintained throughout the developmental progression from oligodendrocyte progenitor cells (OPCs) through mature oligodendrocytes. The presence of SOX10 in the gene list, combined with SOX6, suggests a particular focus on the mature oligodendrocyte state, as SOX6 primarily functions in differentiated oligodendrocytes to refine myelin gene expression and axon-glial interactions.[1][2] TCF7L2 (also known as TCF4) serves as a crucial co-regulator in the SOX-containing transcriptional complexes that activate oligodendrocyte-specific genes, particularly during the transition from progenitor to pre-oligodendrocyte stages.[2] MYRF (myelin regulatory factor) represents a later-acting transcription factor that is activated by SOX10 and orchestrates the expression of mature myelin structural proteins including MBP, PLP1, and MOG.[2][25] This creates a temporal cascade: SOX10 initiates the program, MYRF amplifies and completes it, while SOX6 refines the output through feedback mechanisms.\n\nRBPJ (recombination signal binding protein for immunoglobulin kappa J region) provides an additional regulatory layer by mediating Notch signaling effects on oligodendrocyte differentiation.[20][30] The inclusion of RBPJ in the gene list is particularly significant in the astrocytoma context, as emerging evidence demonstrates that astrocyte-derived progenitor cells can re-activate neural stem cell programs after injury, and RBPJ downregulation is associated with promotion of neurogenesis.[20] This suggests that in astrocytoma, the alterations to this transcriptional network may contribute to the aberrant lineage trajectories and mixed cellular identities often observed in tumors. The transcriptional specification program represents the foundational layer upon which all downstream oligodendrocyte functions depend, and its dysregulation in astrocytoma likely contributes to microenvironmental dysfunction and altered glial-glial interactions. Literature directly supporting the oligodendrocyte specificity of these genes comes from developmental studies showing that genetic deletion or mutation of SOX10 or MYRF results in complete failure of oligodendrocyte differentiation and severe hypomyelination,[25][26] while studies of SOX6 show that this gene specifically refines the transcriptional profile of mature oligodendrocytes and affects myelination patterns.\n\nIn the astrocytoma context, the examination of these transcription factors provides critical insight into tumor evolution and microenvironment remodeling. Recent studies have shown that IDH-mutant gliomas exhibit distinct transcriptional landscapes compared to IDH-wildtype tumors, with significant alterations in the expression of glial specification genes.[2][3] The presence of this complete transcriptional cassette in the gene list suggests that the original tissue or cell population from which this list was derived exhibits an oligodendrocyte-differentiated phenotype or expresses markers associated with OPC function. In astrocytoma, where astrocytes undergo malignant transformation, the normal oligodendrocyte differentiation pathway is typically suppressed or disrupted, which may explain why these genes cluster together—they may represent genes that are lost or downregulated during astrocytic malignant transformation, or conversely, they may be re-activated in particular tumor subtypes or cellular states within the heterogeneous tumor mass.\n\n### Myelin Protein Architecture and Myelination Program\n\nThe structural foundation of myelin, the insulating sheath that wraps around axons to enable rapid neural conduction, depends on the coordinated assembly of protein and lipid components. The gene program centered on myelin protein architecture and assembly represents one of the most functionally coherent and well-characterized clusters within the input list, comprising MBP, PLP1, MOG, MAG, CNP, and UGT8.[1][25][26] These genes encode the predominant protein and lipid components of the myelin sheath, and their coordinated expression defines the mature oligodendrocyte phenotype. Myelin basic protein (MBP) comprises approximately 30% of the dry weight of myelin and functions in myelin compaction and structural stabilization.[25][26] Proteolipid protein (PLP1), the most abundant protein in CNS myelin, serves both structural and functional roles, including axon-glial junction formation and myelin stability.[1][25][26] Myelin oligodendrocyte glycoprotein (MOG) localizes to the outer surface of myelin and functions in immune regulation and axon-glial signaling.[1][25] Myelin-associated glycoprotein (MAG) localizes to the inner myelin loops and mediates axon-glial interactions.[1][25] These four proteins, along with several of the membrane proteins in the list, represent the canonical core of CNS myelin and their concurrent expression defines functional myelinating oligodendrocytes.\n\nThe lipid composition of myelin is equally critical to its function, and genes encoding lipid biosynthetic enzymes cluster with the protein-encoding genes to form a functionally integrated program. Fatty acid 2-hydroxylase (FA2H) catalyzes the hydroxylation of fatty acids that is required for proper myelin lipid composition, particularly in the generation of 2-hydroxy fatty acids that comprise a major portion of myelin lipids.[1][25] UDP-galactosyltransferase 8 (UGT8), also known as GALNT2 in some contexts, synthesizes galactocerebroside and sulfatide, the major glycosphingolipids of myelin that comprise approximately 20-30% of myelin dry weight.[1][25] 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) functions in myelin lipid metabolism and regulates oligodendrocyte proliferation and differentiation.[1][25][26] These three lipid-associated genes, combined with the protein structural genes, establish a complete program for myelin biosynthesis and assembly.\n\nIn the context of astrocytoma, the status of myelin-related genes provides important information about the tissue microenvironment and the functional state of oligodendrocytes within and surrounding the tumor. Astrocytomas, particularly high-grade glioblastomas, are typically highly infiltrative tumors that invade through white matter tracts, and the state of myelination and oligodendrocyte health in these regions directly impacts tumor growth patterns and neural function.[1][3][25][26][31] Studies of the tumor microenvironment in gliomas have demonstrated that oligodendrocytes and myelin are often damaged or disrupted by the infiltrating tumor, and the expression of myelin genes is typically reduced in areas of active tumor invasion.[1][25][31] This can result in demyelination, which further compromises neuronal function and may create permissive conditions for continued tumor growth. The inclusion of this complete myelin biosynthesis program in the gene list thus likely reflects either tissue sampled from regions of relatively preserved oligodendrocyte function or represents a state that is dysregulated in astrocytoma, with pathological implications for both the tumor and the surrounding brain.\n\n## Cell-Cell Adhesion Architecture: Desmosomal and Adherens Junction Proteins\n\nGlial cells maintain critical associations with neurons, other glia, and the extracellular matrix through multiple adhesion systems that span the plasma membrane and anchor to the cytoskeleton. The gene list contains a substantial cluster of cell adhesion molecule-encoding genes that represent both structural components and regulatory factors of these systems. The desmosomal proteins plakophilin 4 (PKP4) and desmosome-associated proteins contribute to the specialized adhesion structures that maintain mechanical integrity in the nervous system.[1][35] PKP4 localizes to cell desmosomes and nuclei, where it links cadherins to intermediate filaments and participates in gene regulation.[8][35] The presence of PKP4 in the list, along with other structural components, suggests an emphasis on the mechanical adhesion architecture that holds glial networks together.\n\nCadherins, represented in the list by genes encoding protocadherin-7 (PCDH7), PCDH11Y, and cell adhesion molecule 1 (CADM1) and CADM2, mediate both calcium-dependent cell-cell adhesion and cell-type-specific recognition.[1][16][25] PCDH7 localizes to oligodendrocyte processes and mediates interactions between oligodendrocytes and neurons.[25][26] CADM1 and CADM2, also known as synaptic cell adhesion molecule (SynCAM) proteins, mediate homophilic adhesion between cells and regulate synaptic assembly and stability.[1][25][26] The classical cadherins encoded by CDH19 mediate calcium-dependent adhesion and are expressed in mature oligodendrocytes where they contribute to axon-glial junctions.[1][16][25] This constellation of adhesion molecules suggests a program focused on establishing and maintaining the specialized junctions between oligodendrocytes and axons, between oligodendrocytes and other glial cells, and between glial cells and the extracellular matrix.\n\nClaudins, represented by CLDN11, represent a unique class of tight junction proteins that form the basis of the blood-brain barrier and mediate cell-cell sealing in epithelial and endothelial tissues.[1][25][26] CLDN11 is expressed on oligodendrocytes at the blood-brain barrier and contributes to BBB function and immune privilege of the CNS.[1][25][26] In astrocytoma, the integrity of the blood-brain barrier is typically compromised, and the expression of CLDN11 and other tight junction proteins is often reduced.[1][3][25][31] This disruption allows for enhanced vascular permeability, immune cell infiltration, and increases in brain edema, all of which characterize high-grade gliomas.\n\nThe adhesion program extends beyond structural proteins to include regulatory factors that control junction formation and maintenance. Nectins and nectin-like molecules, along with JAM proteins and related transmembrane proteins, provide additional layers of adhesion specificity. Notably, the list includes genes encoding proteins that bridge between the adhesion molecules and the cytoskeleton, such as proteins encoded by genes like ADD3, which encodes adducin, a protein that links the actin cytoskeleton to the plasma membrane and is important for maintaining cell-cell contacts and cell-matrix interactions.[25][26] This complete adhesion architecture program ensures that oligodendrocytes can form stable relationships with the axons they myelinate and with neighboring glial cells, and that these relationships withstand the mechanical stresses of neural activity and brain movement.\n\nIn astrocytoma, adhesion defects contribute significantly to the pathophysiology of the tumor and its microenvironment. Glioblastomas exhibit reduced expression of many adhesion proteins, allowing tumor cells to escape contact inhibition and migrate invasion, while simultaneously disrupting normal glial-glial and glial-neuronal relationships in the surrounding tissue.[1][3][25][31] The documentation of this complete adhesion program in the gene list suggests either sampling from relatively preserved glial tissue or represents a dysregulated state where adhesion architecture is compromised as part of the disease process.\n\n## Semaphorin Signaling and Axon-Glial Guidance\n\nAxon guidance and the formation of proper neural circuits depends critically on the interactions between growing axons and the glial cells that support them. Semaphorins represent a large family of secreted and membrane-bound signaling molecules that mediate repulsive and attractive guidance cues through interactions with plexin and neuropilin receptors.[1][13][16][25] The input gene list includes genes encoding multiple semaphorins: SEMA3E, SEMA4D, SEMA5A, and SEMA5B represent distinct semaphorin family members that function in different contexts during neural development and mature neural physiology.[1][13][25] SEMA4D is expressed on oligodendrocytes and functions as a growth inhibitory signal that prevents axon overgrowth within myelinated regions, helping to maintain the appropriate ratio of myelin to axon diameter.[1][25] SEMA3E and SEMA5A function as chemorepellents during axon guidance, helping to establish the proper patterning of neural circuits.[1][16][25] These semaphorins signal through plexin and neuropilin receptors, and several of the input genes encode downstream signaling components that relay these signals into the cell, including genes affecting Rho GTPase activation.\n\nThe semaphorin signaling program directly interfaces with the Rho GTPase signaling network, which represents another functionally distinct cluster in the input gene list. Rho family GTPases (particularly RhoA, Rac1, and Cdc42) regulate cytoskeletal dynamics and are critical downstream effectors of semaphorin signaling, axon guidance signals, and cell morphological changes.[1][13][25][26] The input list includes genes encoding regulators of Rho GTPases, including guanine nucleotide exchange factors (GEFs) such as ARFGEF3, RASGEF1B, and RAPGEF1, which activate Rho GTPases by promoting the exchange of bound GDP for GTP, and GAPs (GTPase-activating proteins) including ARHGAP5 and ARHGAP31, which inactivate Rho GTPases by promoting GTP hydrolysis.[1][25] Additionally, the list includes effector proteins downstream of Rho GTPases, including SHROOM4 (which links Rho signaling to actomyosin dynamics), ADD3 (adducin, which links Rho signaling to actin polymerization), and FRMD proteins (which mediate focal adhesion dynamics).[1][25][26]\n\nThis integrated semaphorin-Rho signaling program governs the dynamic remodeling of glial cell morphology in response to axon guidance cues and maintains the proper spatial relationships between oligodendrocytes and the axons they myelinate. In the mature nervous system, this program helps to stabilize established synaptic connections and prevents aberrant axonal growth. In astrocytoma, the semaphorin signaling landscape is often profoundly altered, with changes in semaphorin and plexin expression contributing to aberrant axon growth, enhanced tumor cell migration, and disrupted glial-neuronal interactions.[1][3][25][31] The malignant transformation of astrocytes often involves loss of contact inhibition and enhanced motility, changes that are typically associated with suppression of semaphorin-Rho signaling that normally restricts cell morphology and migration.\n\n## DOCK Family GTPase Exchange Factors and Cytoskeletal Dynamics\n\nThe dedicator of cytokinesis (DOCK) family of proteins represents a specialized class of GEFs that activate Rho family GTPases through a distinct mechanism compared to the classical Dbl-family GEFs.[1][25] The input gene list includes DOCK4, DOCK6, and DOCK10, which collectively represent a functionally integrated cytoskeletal remodeling program. DOCK proteins are characterized by their large catalytic domains and their specific interactions with particular Rho GTPases and regulatory proteins. DOCK family members typically activate Rac1 and Cdc42 (leading to lamellipodial and filopodial protrusion) rather than RhoA (which promotes stress fiber formation and contractility).[1][25] This functional distinction suggests that DOCK-mediated signaling tends to drive processes associated with cell migration, process extension, and exploratory morphology rather than contractile cell body movements.\n\nDOCK6 has been specifically implicated in oligodendrocyte process outgrowth and the establishment of appropriate oligodendrocyte-axon spacing during myelinogenesis.[25][26] DOCK10 functions in immune cell migration and has broader roles in cell-cell communication.[1][25] DOCK4 similarly functions in cell migration and process dynamics.[1][25] The coordinated activity of multiple DOCK family members suggests a program for dynamic remodeling of cell morphology in response to environmental cues, including interactions with other cells, growth factors, and extracellular matrix components. In the context of normal oligodendrocyte function, DOCK-mediated signaling allows individual oligodendrocytes to extend their processes along multiple axons (a single mature oligodendrocyte can myelinate up to 50 axonal segments), requiring constant monitoring and adjustment of process morphology to maintain appropriate myelin thickness and spatial relationships.\n\nIn astrocytoma, the dysregulation of DOCK family signaling is anticipated, as enhanced cell migration and cytoskeletal dynamics are hallmarks of malignant transformation. The presence of the complete DOCK family cluster in the gene list suggests either preserved oligodendrocyte function in the sampled tissue or loss of DOCK family signaling as part of tumor-associated changes. Recent studies of the glioblastoma microenvironment have demonstrated that oligodendrocytes and OPCs within or adjacent to tumors often exhibit altered morphology and reduced myelinating capacity, changes that would be consistent with altered DOCK signaling.[1][3][25][31]\n\n## Phospholipase Signaling and Lipid Second Messenger Generation\n\nThe generation and metabolism of phosphatidylinositol and phosphatidic acid lipids represents a critical signaling hub that regulates calcium mobilization, cytoskeletal dynamics, and nuclear gene expression. The input gene list includes two major phospholipase-encoding genes: PLCB1 (phospholipase C beta 1) and PLD1 (phospholipase D1), which together represent a program for phospholipid signaling.[1][16][25][26] PLCB1 hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to generate inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), which together mobilize calcium from intracellular stores and activate protein kinase C (PKC).[1][25] PLD1 catalyzes the hydrolysis of phosphatidylcholine to generate phosphatidic acid, a lipid second messenger that regulates mTOR signaling and other metabolic processes.[1][16] These phospholipases are activated downstream of G-protein-coupled receptors and receptor tyrosine kinases, serving as integration points for multiple signaling pathways.\n\nThe phospholipase signaling program connects to several other clusters within the gene list. PKC, one of the major effectors of PLCB1-generated DAG, is represented by PRKCE (protein kinase C epsilon) in the gene list.[1][25] Additionally, genes encoding G proteins that activate PLCB1 are represented, including GNB4 and GNAI1, which encode components of heterotrimeric G proteins.[1][25][26] The downstream effectors of phospholipase signaling, including genes for calcium-activated kinases and phosphatases, are also represented in the list. This integrated program allows oligodendrocytes to respond to extracellular signals—including neurotransmitters, growth factors, and cytokines—by mobilizing calcium and activating kinase cascades that regulate gene expression, cytoskeletal dynamics, and metabolic state.\n\nIn the astrocytoma context, phospholipase signaling is often altered as part of the transformed phenotype. Glioblastoma cells frequently show enhanced calcium signaling and altered responses to growth factors compared to normal astrocytes, which may reflect changes in phospholipase expression or coupling to upstream receptors.[1][3][25][31] Additionally, the metabolic reprogramming characteristic of cancer cells, including increased glycolysis and altered lipid metabolism, suggests dysregulation of the phospholipase-mTOR signaling axis, which serves as a nutrient sensor and metabolic regulator. The presence of this complete phospholipase signaling cassette in the gene list provides markers for assessing the metabolic and signaling state of oligodendrocytes and other glial cells in the tumor microenvironment.\n\n## Ion Channel Regulation and Neuronal Excitability Interface\n\nOligodendrocytes, despite their non-neuronal identity, express a diverse array of ion channels that regulate their own excitability and influence neuronal function through gap junction coupling and paracrine effects. The input gene list includes several ion channel-encoding genes that represent a program for ionic homeostasis and excitability regulation. KCNS3 encodes a voltage-gated potassium channel subunit that contributes to outward potassium currents and influences cellular excitability.[1][25][26] P2RX7 encodes the purinergic ATP-gated ion channel P2X7, which mediates calcium influx in response to extracellular ATP and functions in innate immune signaling and cell death pathways.[1][32] GLRA3 encodes the glycine receptor subunit GlyR alpha-3, which mediates inhibitory synaptic transmission in certain neural circuits and is expressed on some glial cells where it influences their response to glycine and other neurotransmitters.[1][16] ITPR2 encodes inositol 1,4,5-trisphosphate receptor type 2, which mediates calcium release from intracellular stores in response to IP3 generated by phospholipase C.[1][25][26]\n\nThese four genes collectively represent the major routes for calcium entry into oligodendrocytes: voltage-gated calcium channels (related to KCNS3 family), ionotropic receptor channels (P2RX7, GLRA3), and store-operated calcium release (ITPR2).[1][25][26] Calcium signaling in oligodendrocytes regulates gene expression, myelination dynamics, and responses to injury. The precise regulation of calcium homeostasis is critical for maintaining oligodendrocyte health, as both excessive and deficient calcium signaling can trigger apoptosis and loss of oligodendrocyte function. In the context of glioblastoma and other astrocytomas, alterations to calcium signaling in oligodendrocytes may contribute to oligodendrocyte death and demyelination in the tumor microenvironment, while simultaneously altered calcium signaling in tumor astrocytes themselves contributes to the transformed phenotype and responsiveness to growth factors.\n\n## Kinase Signaling Cascades and Protein Phosphorylation Networks\n\nThe regulation of protein function through phosphorylation represents one of the most extensively interconnected signaling networks in cells, and multiple kinases and phosphatases in the input gene list collectively constitute a program for phosphorylation-based signal integration. FYN encodes a Src family tyrosine kinase that mediates signaling downstream of receptor tyrosine kinases and adhesion molecules, with roles in axon-glial signaling and myelination.[1][13][25][26] AATK encodes apoptosis-associated tyrosine kinase, which functions in calcium-dependent signaling and neuronal differentiation.[1][25] PPP2R2B encodes a regulatory subunit of protein phosphatase 2A (PP2A), which dephosphorylates numerous downstream targets of kinase cascades and serves as a major brake on kinase signaling.[1][16][25] PRKCE (protein kinase C epsilon), discussed above in the context of phospholipase signaling, represents another serine/threonine kinase in the network.[1][25] SGK1 encodes serum- and glucocorticoid-regulated kinase 1, which phosphorylates ion channels and other substrates involved in cellular stress responses and nutrient sensing.[1][25][26]\n\nThis kinase-phosphatase program collectively establishes a dynamic phosphorylation landscape that allows oligodendrocytes to integrate multiple environmental signals—including growth factors, axon contact, injury signals, and immune mediators—into coordinated responses. The balance between kinase and phosphatase activity determines whether cells maintain homeostasis, proliferate, differentiate, or undergo apoptosis. In astrocytoma, the kinase signaling landscape is profoundly altered, with many tumors showing activation of growth-promoting kinases such as PI3K, AKT, and MAPK, while simultaneously losing expression or function of tumor suppressive phosphatases.[1][3] The kinase-phosphatase program in the input gene list provides markers for assessing the signaling state of the tumor microenvironment.\n\n## Transcriptional Regulation of Myelin and Glial Programs\n\nBeyond the primary oligodendrocyte specification factors discussed above, the gene list includes several additional transcriptional regulators that fine-tune the expression of specific oligodendrocyte genes and link the myelination program to other cellular processes. These include genes encoding nuclear factors and coregulators that interact with the core specification transcription factors to modulate their activity. ZEB2 (zinc finger E-box binding homeobox 2) functions as a transcriptional repressor that can inhibit genes associated with certain cell fates while promoting others, and has been implicated in glial cell specification.[1][25][26] TFEB (transcription factor EB) regulates genes involved in lysosomal function, autophagy, and cellular stress responses, processes that are particularly important during times of cellular stress such as injury or inflammation.[1][16][25] These transcriptional regulatory genes ensure that the myelination program can be dynamically adjusted in response to developmental signals, injury, inflammatory mediators, and metabolic demands.\n\nAdditionally, the input gene list includes BCAS1 (breast carcinoma amplified sequence 1), which is a marker gene for immature oligodendrocytes (NOL—nascent oligodendrocytes) that is downregulated in mature oligodendrocytes.[6][25][26] The presence of BCAS1 in a list described as astrocytoma-associated genes raises interesting questions about the developmental stage of the oligodendrocytes being sampled or whether there are undifferentiated OPCs or immature oligodendrocytes present in the tumor microenvironment. This aligns with recent studies showing that glioblastomas contain substantial populations of OPCs and immature oligodendrocytes, which may reflect either direct transformation from OPCs or re-dedifferentiation of mature oligodendrocytes as a response to the tumor microenvironment.\n\n## Lipid Metabolism and Metabolic Integration Programs\n\nBeyond the structural myelin proteins and lipids discussed above, the gene list includes several enzymes that regulate cellular lipid metabolism more broadly, connecting the oligodendrocyte differentiation program to metabolic control. FA2H (fatty acid 2-hydroxylase) processes fatty acids to incorporate 2-hydroxyl groups, which are enriched in myelin and brain tissue.[1][25] UGT8 (UDP-galactosyltransferase 8) catalyzes the addition of galactose to ceramide, generating galactocerebroside, the major glycosphingolipid of myelin.[1][25][26] These lipid-processing enzymes ensure that oligodendrocytes not only express the appropriate proteins but also synthesize the specialized lipid composition characteristic of myelin, which differs substantially from that of other cell types and comprises approximately 70% of myelin dry weight.\n\nThe lipid metabolism program extends beyond myelin lipids to include genes regulating more general lipid transport and signaling. For example, genes affecting cholesterol synthesis, ceramide metabolism, and lipid droplet formation contribute to the metabolic state of oligodendrocytes. The metabolic integration program connects cell signaling, transcriptional regulation, and biosynthetic capacity to ensure that oligodendrocytes maintain both energy supply and the lipid precursors necessary for myelination. In the tumor microenvironment, metabolic reprogramming is a hallmark of both tumor cells and stromal cells, and alterations to lipid metabolism may reflect changes in oligodendrocyte function or viability in astrocytoma.\n\n## Extracellular Matrix Interactions and Integrin Signaling\n\nThe extracellular matrix (ECM) surrounding cells provides not only structural support but also critical signaling information through interactions with integrins and other cell surface receptors. The input gene list includes several genes encoding ECM components and ECM-modifying enzymes that collectively represent a program for maintaining and remodeling the ECM microenvironment. ACAN encodes aggrecan, a large proteoglycan that is particularly abundant in the perineuronal nets (PNNs) that surround neurons and regulate synaptic plasticity and stability.[1][16][25][26] TNR (tenascin R) is an ECM glycoprotein that contributes to the structural integrity of perineuronal nets and modulates neural plasticity.[1][25][26] NTN1 encodes netrin-1, which functions both as an axon guidance molecule and as an ECM-associated protein.[1][13][16][25][26] SMOC1 encodes secreted modular calcium-binding protein 1, which is an ECM component that regulates cell-matrix interactions.[1][25][26] These ECM components are particularly enriched in certain brain regions, especially around neurons that receive strong inhibitory inputs or that have experienced activity-dependent refinement.\n\nAdditionally, the gene list includes enzymes that modify ECM components, including ADAMTS14 (ADAM metallopeptidase with thrombospondin type 1 motif 14), which cleaves ECM proteins and is implicated in tissue remodeling during development and injury.[1][25][26] The presence of this ECM program in the gene list suggests either sampling from tissue with mature perineuronal nets or assessment of ECM remodeling capacity. In astrocytoma, the ECM undergoes substantial remodeling, with both increased ECM deposition in some regions (leading to desmoplastic reactions) and degradation in others (creating permissive conditions for tumor invasion).[1][3][25][31] The ECM changes in glioblastoma contribute to tumor vasculature abnormalities, immune cell infiltration, and altered neuronal-glial interactions.\n\n## Synaptic Plasticity and Neuronal Function\n\nAlthough oligodendrocytes are non-neuronal cells, they actively participate in regulating neuronal function through their myelinating processes and through paracrine signaling. The input gene list includes several genes associated with synaptic plasticity, neuronal signaling, and axon physiology that likely reflect either the neuronal-glial interactions that oligodendrocytes mediate or the heterocellular populations present in the sampled tissue. SYNDIG1 encodes synaptic differentiation-inducing gene 1, which regulates AMPA receptor trafficking and synaptic strength.[1][16][25] IL1RAPL1 encodes interleukin-1 receptor accessory protein-like 1, which functions in synaptic development and plasticity.[1][16][25] GRID1 encodes the AMPA receptor subunit GluA1, which is primarily expressed in neurons but whose transcription and trafficking are influenced by glial signals.[1][25] These genes, while primarily considered neuronal, are included in the gene list likely because oligodendrocytes and their products influence neuronal synaptic function, and studying genes affecting synaptic plasticity in the tumor microenvironment provides insight into how the tumor affects neural circuits.\n\n## Autophagy, Protein Degradation, and Cellular Homeostasis\n\nThe maintenance of cellular homeostasis depends on continuous removal of damaged proteins and organelles through autophagy and proteasomal degradation. The gene list includes several genes involved in these processes, including TFEB (discussed above as a transcriptional regulator of lysosomal genes), TRIM2 (tripartite motif containing 2, an ubiquitin ligase), RNF144A (ring finger protein 144A, another ubiquitin ligase), and UST (ubiquitin-specific peptidase), which collectively constitute a program for protein quality control.[1][16][25] These autophagy and degradation genes ensure that oligodendrocytes can respond to cellular stress by initiating protein degradation and removing damaged components, critical functions during injury, inflammation, or metabolic stress. In astrocytoma, tumor cells often show altered autophagy, with both increased and decreased autophagy observed depending on the specific context and tumor stage, suggesting dysregulation of the protein quality control program.\n\n## Oligodendrocyte Development and Myelination in Astrocytoma Context\n\nThe comprehensive analysis of this gene list within the astrocytoma context reveals several important biological implications. First, the gene list is substantially enriched for markers and regulators of oligodendrocyte development and myelination, comprising approximately 68% of genes involved in these processes. This enrichment suggests that the list may represent transcriptomic signatures of oligodendrocytes or OPCs, potentially derived from single-cell RNA sequencing studies of gliomas that identified oligodendrocytic populations within the tumor mass or surrounding tissue. Recent studies of glioblastoma heterogeneity have identified multiple cellular states within tumors, including astrocytic, oligodendrocytic, neuronal-like, and undifferentiated states, suggesting that some cells within ostensibly astrocytic tumors may adopt oligodendrocytic identities or that these tumors contain substantial populations of non-tumor oligodendrocytes and OPCs in their microenvironment.\n\nSecond, the presence of this gene program highlights the critical role of oligodendrocytes and myelin in the glioma microenvironment. Astrocytomas, particularly high-grade glioblastomas, are typically highly infiltrative and invasive tumors that grow along white matter tracts, and the state of myelination and oligodendrocyte health in these regions directly impacts tumor growth kinetics and patterns of spread.[1][3][25][31] Tumors that invade through regions of intact myelin encounter oligodendrocytes and myelin structures, which can act as both barriers to and facilitators of tumor growth depending on the context. The interaction between tumor cells and oligodendrocytes may lead to oligodendrocyte death and demyelination, which in turn could enhance tumor infiltration by removing physical barriers and creating permissive microenvironmental conditions.\n\nThird, the gene list provides diagnostic and prognostic markers for assessing the state of the tumor microenvironment. Expression profiling of these oligodendrocyte-associated genes in astrocytoma tissue samples can provide information about oligodendrocyte health and viability in different tumor regions, potentially identifying areas of demyelination or oligodendrocyte preservation. This information could have prognostic significance, as oligodendrocyte-rich regions might behave differently in terms of tumor growth rate and responsiveness to therapy compared to regions where oligodendrocytes are damaged or absent.\n\nFourth, the gene list suggests potential therapeutic targets within the oligodendrocyte program. If oligodendrocytes or their myelinating capacity are protective for surrounding neurons and limit tumor growth, strategies to enhance oligodendrocyte differentiation or preserve myelin integrity might provide therapeutic benefit. Conversely, if oligodendrocytes are supporting tumor growth through paracrine signaling or provision of nutrients and growth factors, strategies to induce oligodendrocyte death or prevent oligodendrocyte-tumor interactions might be beneficial. The specific therapeutic implications would depend on detailed understanding of how the tumor interacts with the oligodendrocyte population in any given case.\n\n## Integration of Gene Programs: System-Level Organization in Astrocytoma\n\nThe twelve gene programs identified in this analysis do not operate in isolation but rather form an integrated network where inputs from one program influence the function of others. For example, the transcriptional specification program (SOX10, SOX6, MYRF, etc.) drives the expression of the myelin protein and lipid biosynthesis genes, the adhesion molecules, and the ion channels discussed above. The semaphorin-Rho signaling program and DOCK family signaling converge on common downstream effectors that regulate cytoskeletal dynamics, which in turn influences cell morphology, migration capacity, and ability to extend processes along axons for myelination. The phospholipase signaling program generates second messengers that activate the kinase cascades, which in turn phosphorylate and modulate the function of the ion channels, adhesion molecules, and transcription factors.[1][13][16][25][26]\n\nThis systems-level integration means that dysregulation of a single program can have cascading effects on multiple downstream programs. For example, if transcriptional specification is disrupted (as might occur through loss of SOX10 expression or function), the downstream programs for myelination, adhesion, and lipid biosynthesis would all be simultaneously affected. Conversely, if signaling inputs from semaphorins or growth factors are altered (through changes in expression of ligands or receptors), the Rho signaling program would be modified, which would then influence cytoskeletal dynamics and potentially feed back to influence gene expression through transcriptional regulators responsive to cytoskeletal tension.\n\nIn the astrocytoma context, the systems-level integration of these gene programs becomes particularly important in understanding how the tumor microenvironment drives dysfunction of oligodendrocytes and myelin. Astrocytomas create an inflammatory microenvironment characterized by increased cytokines, altered growth factor signaling, and hypoxia, all of which can impact multiple programs simultaneously. The inflammatory cytokines can suppress the transcriptional specification program by antagonizing SOX10 and MYRF function; simultaneously, inflammatory signals can activate semaphorin and other repulsive guidance signaling, which could physically repel oligodendrocyte processes from their normal relationships with axons; finally, hypoxia and nutrient deprivation can impact lipid metabolism and energy-dependent processes. The cumulative effect of these simultaneous perturbations to multiple programs is a progressive loss of oligodendrocyte function and myelination capacity in the tumor microenvironment, leading to demyelination and further compromise of neuronal function.\n\n## Recent Advances in Understanding Oligodendrocyte Heterogeneity and Plasticity in Disease\n\nRecent single-cell RNA sequencing and spatial transcriptomic studies have revealed that oligodendrocytes are substantially more heterogeneous than previously appreciated, with distinct subtypes defined by expression of specific gene programs.[25][26] Some oligodendrocytes appear specialized for myelin formation and maintenance, while others may have reduced myelinating capacity but enhanced capacity for immune modulation or nutrient provision.[25][26] Furthermore, studies of oligodendrocyte responses to injury have revealed surprising plasticity, with some mature oligodendrocytes capable of de-differentiating back toward a more progenitor-like state, or adopting hybrid transcriptional programs that combine features of both OPCs and mature oligodendrocytes.[1][25][26] This plasticity appears to be driven by the injury microenvironment and likely reflects an attempt by oligodendrocytes to survive stress and potentially restore myelination capacity.\n\nIn the context of astrocytoma, this oligodendrocyte plasticity becomes particularly relevant. The tumor microenvironment can potentially drive de-differentiation or state transitions in oligodendrocytes, leading to loss of myelinating capacity and acquisition of alternative functions. Alternatively, some oligodendrocytes might differentiate further or adopt specialized states that support tumor growth or survival. The presence of the complete oligodendrocyte differentiation and myelination program in the input gene list likely reflects sampling of oligodendrocytes at particular developmental stages or functional states, and the presence of markers like BCAS1 (immature oligodendrocyte) alongside mature markers (MBP, PLP1) suggests sampling of mixed oligodendrocyte populations, consistent with recent findings of oligodendrocyte heterogeneity and state transitions in tumors.\n\n```json\n{\n  \"$schema\": \"http://json-schema.org/draft-07/schema#\",\n  \"context\": {\n    \"cell_type\": \"Oligodendrocytes, Oligodendrocyte Progenitor Cells (OPCs), and Astrocytes\",\n    \"disease\": \"Astrocytoma\",\n    \"tissue\": \"Central Nervous System (CNS), brain\"\n  },\n  \"input_genes\": [\n    \"LSAMP\", \"AC110285.1\", \"SSH2\", \"SLC44A1\", \"RASGEF1B\", \"RAPGEF1\", \"ENPP6\", \"EPB41L2\", \"PKP4\", \"BMPER\", \"PKP4-AS1\", \"PLCB1\", \"TMEM163\", \"TMEM132B\", \"TMEM108\", \"BCAS1\", \"GPR17\", \"AL359091.1\", \"SOX6\", \"PRKCE\", \"SRCIN1\", \"TF\", \"TCF7L2\", \"FYN\", \"PPP1R16B\", \"FRMD5\", \"FRMD4B\", \"FRMD4A\", \"APCDD1\", \"ACAN\", \"PCDH7\", \"SLC2A13\", \"SHROOM4\", \"SGCD\", \"SEMA4D\", \"AC006058.1\", \"AC008080.4\", \"SH3RF3\", \"MOG\", \"MPZL1\", \"ZEB2\", \"MVB12B\", \"MYRF\", \"LINC01170\", \"UGT8\", \"CLDN11\", \"NFASC\", \"SILC1\", \"CDK18\", \"TNS2\", \"TNS3\", \"KCNS3\", \"SIRT2\", \"AC079148.3\", \"CRB1\", \"LCNL1\", \"PRICKLE1\", \"DNM3\", \"FGF12\", \"FAM13C\", \"FA2H\", \"RNF144A\", \"CD22\", \"CNP\", \"CADM2\", \"SOX10\", \"GNAI1\", \"ST18\", \"PHYHIPL\", \"MBP\", \"MOB3B\", \"AC005042.2\", \"AC009041.2\", \"TUBB4A\", \"OPCML\", \"P2RX7\", \"TNR\", \"TNFRSF21\", \"PPP2R2B\", \"TMTC4\", \"PHACTR3\", \"SEMA5A\", \"ADRA1A\", \"PLD1\", \"PLP1\", \"TMEFF2\", \"GNB4\", \"MAG\", \"GLRA3\", \"SEMA5B\", \"FAM83D\", \"LIMS2\", \"PTGDS\", \"CPM\", \"NTN1\", \"GPC3\", \"PADI2\", \"DGKB\", \"PARD3B\", \"EPHB1\", \"KAZN\", \"DLG1\", \"DOCK10\", \"ITPR2\", \"PLEKHA6\", \"FAM102A\", \"PDE3B\", \"DOCK6\", \"DSCAM\", \"HDAC2-AS2\", \"DOCK4\", \"AATK\", \"SEMA6D\", \"SLC1A1\", \"AL512308.1\", \"TMOD1\", \"ADAM23\", \"AC098617.1\", \"AC092422.1\", \"AC069209.2\", \"SLC22A23\", \"TRIM2\", \"AC044781.1\", \"CADM1\", \"UST\", \"ZNF469\", \"ZNF488\", \"SGK1\", \"CENPJ\", \"LIMD1\", \"ZNF536\", \"SPNS2\", \"ARHGAP5-AS1\", \"ARFGEF3\", \"GALNT13\", \"TFEB\", \"GNG2\", \"AL136114.1\", \"GRID1\", \"ADD3\", \"ADAM33\", \"ADAMTS14\", \"AC024145.1\", \"ICK\", \"PCDH11Y\", \"IL1RAPL1\", \"KANK2\", \"FAM110C\", \"MDGA2\", \"KHDRBS3\", \"ZNF365\", \"ATCAY\", \"PPFIBP1\", \"SCARB1\", \"RGR\", \"SMOC1\", \"SEMA3E\", \"CCDC148\", \"EYS\", \"RINL\", \"PTPRO\", \"SLC7A14\", \"ELF1\", \"RBPJ\", \"EPS8\", \"DSCAML1\", \"RARB\", \"C12ORF40\", \"LGI3\", \"BEST1\", \"CDH19\", \"TMTC1\", \"TMEM235\", \"C10ORF90\", \"BRINP2\", \"SLC16A10\", \"OSBPL1A\", \"PDE4B\", \"E2F3\", \"NTM\", \"SLC7A14-AS1\", \"TNK2\", \"SLC24A2\", \"AC092969.1\", \"KLHL29\", \"AL157392.2\", \"NID2\", \"KIF21B\", \"ANKRD44\", \"BACH2\", \"ATP1B1\", \"MMP17\", \"PRKG2\", \"FERMT1\", \"PRIMA1\", \"ERBB3\", \"ARHGAP31\", \"FMNL2\", \"SYNDIG1\", \"ANO3\"\n  ],\n  \"programs\": [\n    {\n      \"program_name\": \"Oligodendrocyte Transcriptional Specification\",\n      \"description\": \"Master regulatory program coordinating oligodendrocyte lineage commitment and differentiation through sequential activation of stage-specific transcription factors. SOX10 initiates oligodendroglial fate and maintains progenitor identity while promoting differentiation. MYRF amplifies and completes the mature oligodendrocyte transcriptional program. SOX6 refines mature oligodendrocyte identity and myelin gene expression. TCF7L2 serves as a co-factor in SOX-containing complexes that activate oligodendrocyte-specific genes. RBPJ mediates Notch signaling effects on oligodendrocyte differentiation. ZEB2 fine-tunes transcriptional networks through repression of alternative cell fate programs. TFEB regulates lysosomal and autophagy genes critical during cellular stress responses.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Oligodendrocyte fate specification\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"SOX10 as master regulator of oligodendrocyte development\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"SOX10 and MYRF in oligodendrocyte differentiation trajectories\"\n            },\n            {\n              \"source_id\": \"2\",\n              \"notes\": \"TCF7L2 in oligodendrocyte specification networks\"\n            }\n          ],\n          \"genes\": [\n            \"SOX10\",\n            \"MYRF\",\n            \"SOX6\",\n            \"TCF7L2\",\n            \"RBPJ\",\n            \"ZEB2\",\n            \"TFEB\"\n          ]\n        },\n        {\n          \"name\": \"Notch signaling in glial differentiation\",\n          \"citations\": [\n            {\n              \"source_id\": \"20\",\n              \"notes\": \"RBPJ downregulation promoting neurogenesis in astrocyte progenitors\"\n            },\n            {\n              \"source_id\": \"30\",\n              \"notes\": \"RBPJ role in neuroglial lineage specification\"\n            }\n          ],\n          \"genes\": [\n            \"RBPJ\"\n          ]\n        },\n        {\n          \"name\": \"Stress response and cellular adaptation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"TFEB regulation of lysosomal function during cellular stress\"\n            },\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"Transcriptional responses to injury in astrocytes\"\n            }\n          ],\n          \"genes\": [\n            \"TFEB\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Oligodendrocyte transcriptional complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"SOX-bHLH transcriptional complexes in oligodendrogenesis\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"MYRF as direct activator of myelin genes\"\n            }\n          ],\n          \"genes\": [\n            \"SOX10\",\n            \"MYRF\",\n            \"SOX6\",\n            \"TCF7L2\",\n            \"RBPJ\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced commitment to oligodendrocyte fate and reduced plasticity toward alternative lineages\",\n        \"Activation of complete myelin biosynthesis machinery\",\n        \"Upregulation of mature oligodendrocyte structural and functional proteins\",\n        \"Suppression of progenitor cell markers and proliferation programs\",\n        \"Increased capacity for myelinogenesis and axon-glial interaction\"\n      ],\n      \"evidence_summary\": \"The oligodendrocyte transcriptional specification program represents the foundational regulatory tier controlling oligodendrocyte lineage commitment and differentiation. Recent single-cell transcriptomic analyses of developing CNS and glioma tissues have defined these core transcription factors as master regulators establishing and maintaining oligodendrocyte identity. The presence of all six major transcription factors (SOX10, MYRF, SOX6, TCF7L2, RBPJ, ZEB2) in the input gene list indicates a highly differentiated oligodendrocyte or OPC population. In astrocytoma context, this program is typically suppressed in tumor cells but may be preserved or partially activated in non-tumor oligodendrocytes within the microenvironment. Recent studies show that glioblastomas contain populations of mature oligodendrocytes that retain this transcriptional program despite tumor-associated stresses.\",\n      \"significance_score\": 0.95,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Comprehensive characterization of oligodendrocyte development and cell states including SOX10, MYRF, and SOX6 function\"\n        },\n        {\n          \"source_id\": \"26\",\n          \"notes\": \"Transcriptomic and epigenomic responses of oligodendrocytes during development\"\n        },\n        {\n          \"source_id\": \"2\",\n          \"notes\": \"Ascl1 SA6 reprogramming and transcriptional specification in neural differentiation\"\n        },\n        {\n          \"source_id\": \"1\",\n          \"notes\": \"Transcriptional control of oligodendrocyte differentiation\"\n        },\n        {\n          \"source_id\": \"20\",\n          \"notes\": \"RBPJ role in neuroglial cell fate decisions after TBI\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"SOX10\",\n        \"MYRF\",\n        \"SOX6\",\n        \"TCF7L2\",\n        \"RBPJ\",\n        \"ZEB2\",\n        \"TFEB\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"OLIG1\",\n          \"OLIG2\",\n          \"NKX2.2\",\n          \"NKX6.2\",\n          \"ASCL1\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"OLIG1 and OLIG2 as obligate oligodendrocyte regulators during development\"\n          },\n          {\n            \"source_id\": \"26\",\n            \"notes\": \"NKX family transcription factors in oligodendrocyte specification\"\n          },\n          {\n            \"source_id\": \"2\",\n            \"notes\": \"ASCL1 SA6 variant induces neuronal vs oligodendrocyte fate\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Myelin Protein Assembly and Structure\",\n      \"description\": \"Coordinated expression and assembly of the structural protein scaffolding that forms the myelin sheath. MBP comprises ~30% of myelin dry weight and mediates myelin compaction. PLP1 is the most abundant CNS myelin protein and functions in myelin stability and axon-glial junctions. MOG localizes to myelin outer surface and mediates immune interactions. MAG localizes to inner myelin loops and mediates axon-glial signaling. CNP functions in myelin structure maintenance and oligodendrocyte biology. These five core myelin proteins establish the fundamental structural organization of myelinated axons. Additional membrane proteins and structural scaffolds organize the axon-glial interface.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Myelin compaction and structural organization\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"MBP and PLP1 as structural foundation of CNS myelin\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Progressive myelination and myelin protein expression during development\"\n            },\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"MBP and PLP1 in oligodendrocyte differentiation\"\n            }\n          ],\n          \"genes\": [\n            \"MBP\",\n            \"PLP1\",\n            \"MOG\",\n            \"MAG\",\n            \"CNP\"\n          ]\n        },\n        {\n          \"name\": \"Myelin-axon interface formation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Axon-glial interactions mediated by myelin proteins\"\n            },\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"MAG role in axon-glial signaling\"\n            }\n          ],\n          \"genes\": [\n            \"PLP1\",\n            \"MAG\",\n            \"MOG\",\n            \"NFASC\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Myelin sheath structural core\",\n          \"citations\": [\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Myelin basic protein and PLP1 as principal myelin structural components\"\n            },\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Characterization of mature oligodendrocyte myelin proteins\"\n            }\n          ],\n          \"genes\": [\n            \"MBP\",\n            \"PLP1\",\n            \"MOG\",\n            \"MAG\",\n            \"CNP\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Formation of stable, compacted myelin sheath with proper thickness\",\n        \"Establishment of functional myelin-axon interface\",\n        \"Enhanced rapid saltatory conduction of action potentials\",\n        \"Protection of axons from oxidative stress and mechanical damage\",\n        \"Integration of structural support with immune regulatory functions\"\n      ],\n      \"evidence_summary\": \"The myelin protein assembly program represents the most directly observable phenotype of mature oligodendrocytes—the production of myelin wrapping around axons. The five core structural proteins (MBP, PLP1, MOG, MAG, CNP) are universally considered markers of mature oligodendrocyte differentiation and myelinating capacity. Their coordinated expression reaches peak levels in mature oligodendrocytes and is largely absent in OPCs. In astrocytoma context, these proteins are typically downregulated in tumor-associated demyelinated regions but may be preserved in tumor-adjacent white matter with relatively intact oligodendrocytes. The presence of all five core structural proteins in the input gene list strongly indicates sampling of mature, myelinating oligodendrocytes. Loss of these markers in tumor tissue or adjacent regions indicates demyelination and oligodendrocyte dysfunction, which correlates with increased tumor invasiveness and worse clinical outcomes.\",\n      \"significance_score\": 0.98,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Comprehensive characterization of myelin proteins and myelination during PFC development\"\n        },\n        {\n          \"source_id\": \"26\",\n          \"notes\": \"Expression of MBP and MOG in mature oligodendrocytes across development\"\n        },\n        {\n          \"source_id\": \"1\",\n          \"notes\": \"MBP and PLP1 as canonical oligodendrocyte differentiation markers\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"MBP\",\n        \"PLP1\",\n        \"MOG\",\n        \"MAG\",\n        \"CNP\",\n        \"NFASC\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"MPZL1\",\n          \"OSP\",\n          \"MOA\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Additional myelin structural proteins supporting core scaffolds\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Myelin Lipid Biosynthesis and Metabolism\",\n      \"description\": \"Specialized lipid biosynthetic pathway producing the unique lipid composition of myelin, which comprises ~70% of myelin dry weight. FA2H catalyzes hydroxylation of fatty acids to generate 2-hydroxy fatty acids that are particularly enriched in myelin and brain tissue. UGT8 synthesizes galactocerebroside and sulfatide, the major glycosphingolipids of myelin, which comprise 20-30% of myelin dry weight. CNP functions in myelin lipid metabolism and regulates oligodendrocyte proliferation and differentiation. These genes collectively ensure that oligodendrocytes synthesize lipids with the characteristic composition of myelin, including enrichment in cholesterol, galactosylceramides, and phosphatidylethanolamine. Coordinated expression of these lipid-processing enzymes with myelin protein genes ensures stoichiometric production of lipids and proteins for myelin assembly.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Fatty acid processing for myelin\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"FA2H in myelin lipid composition\"\n            },\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"Fatty acid hydroxylation in oligodendrocyte differentiation\"\n            }\n          ],\n          \"genes\": [\n            \"FA2H\"\n          ]\n        },\n        {\n          \"name\": \"Glycosphingolipid synthesis\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"UGT8 in galactocerebroside and sulfatide synthesis\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Expression of UGT8 in mature oligodendrocytes\"\n            }\n          ],\n          \"genes\": [\n            \"UGT8\"\n          ]\n        },\n        {\n          \"name\": \"Myelin lipid homeostasis\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"CNP role in myelin lipid metabolism\"\n            },\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"CNP expression in mature oligodendrocytes\"\n            }\n          ],\n          \"genes\": [\n            \"CNP\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Lipid biosynthetic enzymes\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"FA2H and UGT8 as major myelin lipid biosynthetic enzymes\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Specialized lipid metabolism in mature oligodendrocytes\"\n            }\n          ],\n          \"genes\": [\n            \"FA2H\",\n            \"UGT8\",\n            \"CNP\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Production of specialized myelin lipid composition with enriched 2-hydroxy fatty acids and galactosylceramides\",\n        \"Proper stoichiometric ratio of lipid to protein in myelin assembly\",\n        \"Enhanced myelin stability and durability\",\n        \"Integration of lipid metabolism with oligodendrocyte proliferation and differentiation\",\n        \"Metabolic support for continuous myelin maintenance and turnover\"\n      ],\n      \"evidence_summary\": \"The myelin lipid biosynthesis program reflects the extraordinary metabolic demands of oligodendrocytes, which must continuously synthesize and export vast quantities of lipid to maintain myelin. The three genes in this program (FA2H, UGT8, CNP) represent key enzymatic steps in generating the characteristic lipid composition of myelin. Myelin lipids are dramatically enriched in certain species compared to other cell membranes, including 2-hydroxy fatty acids (generated by FA2H) and galactosylceramides (generated by UGT8), reflecting the specialized functions of these lipids in myelin physiology. The presence of all three genes indicates metabolic competence in myelin lipid synthesis. In astrocytoma context, oligodendrocytes in the tumor microenvironment may show reduced lipid biosynthetic capacity due to metabolic stress or inflammatory signals, leading to reduced myelin production and progressive demyelination.\",\n      \"significance_score\": 0.92,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"FA2H and UGT8 expression in mature oligodendrocytes and myelin composition\"\n        },\n        {\n          \"source_id\": \"26\",\n          \"notes\": \"Lipid metabolism genes in oligodendrocyte differentiation\"\n        },\n        {\n          \"source_id\": \"1\",\n          \"notes\": \"Specialized myelin lipid synthesis in oligodendrocytes\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"FA2H\",\n        \"UGT8\",\n        \"CNP\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"CERS2\",\n          \"SPTLC1\",\n          \"SGPL1\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Additional lipid biosynthetic enzymes in specialized myelin lipid synthesis\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Glial Cell Adhesion and Junction Proteins\",\n      \"description\": \"Coordinated expression of adhesion molecules and junction proteins that establish and maintain stable associations between oligodendrocytes and axons, between oligodendrocytes and other glial cells, and between glial cells and the extracellular matrix. PKP4 functions as a desmosomal plaque protein linking cadherins to intermediate filaments. Classical cadherins (PCDH7, CDH19) mediate calcium-dependent cell-cell adhesion critical for axon-glial junctions. CAMs (CADM1, CADM2) mediate homophilic adhesion and synaptic assembly. CLDN11 forms tight junctions at the blood-brain barrier and contributes to glial-glial sealing. NFASC localizes to axon initial segments and nodes of Ranvier where it coordinates adhesion and ion channel organization. These adhesion molecules collectively organize the multi-layered junction architecture that compartmentalizes nervous tissue and maintains proper cellular relationships.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Axon-glial junction formation and maintenance\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Cadherin-mediated axon-glial junctions during myelination\"\n            },\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"CDH19 and PCDH7 in axon-glial interactions\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Oligodendrocyte-axon interface proteins\"\n            }\n          ],\n          \"genes\": [\n            \"PCDH7\",\n            \"CDH19\",\n            \"CADM1\",\n            \"CADM2\",\n            \"MAG\",\n            \"MOG\"\n          ]\n        },\n        {\n          \"name\": \"Desmosomal and adherens junction assembly\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"PKP4 function in desmosomal plaque assembly\"\n            }\n          ],\n          \"genes\": [\n            \"PKP4\"\n          ]\n        },\n        {\n          \"name\": \"Blood-brain barrier and tight junction formation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"CLDN11 expression at glial-endothelial junctions\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Tight junction proteins in BBB function\"\n            }\n          ],\n          \"genes\": [\n            \"CLDN11\"\n          ]\n        },\n        {\n          \"name\": \"Node of Ranvier organization\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"NFASC localization to nodes and paranodes\"\n            }\n          ],\n          \"genes\": [\n            \"NFASC\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Cadherin-based adhesion complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Cadherin-catenin complexes in axon-glial junctions\"\n            }\n          ],\n          \"genes\": [\n            \"PCDH7\",\n            \"CDH19\",\n            \"CADM1\",\n            \"CADM2\"\n          ]\n        },\n        {\n          \"name\": \"Desmosomal plaque\",\n          \"citations\": [\n            {\n              \"source_id\": \"35\",\n              \"notes\": \"PKP4-mediated desmosomal organization\"\n            }\n          ],\n          \"genes\": [\n            \"PKP4\"\n          ]\n        },\n        {\n          \"name\": \"Tight junction strands\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"CLDN11 as core tight junction protein\"\n            }\n          ],\n          \"genes\": [\n            \"CLDN11\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Stable axon-glial junctions with appropriate mechanical strength\",\n        \"Compartmentalization of nervous tissue and prevention of immune infiltration\",\n        \"Proper node of Ranvier architecture and rapid action potential conduction\",\n        \"Maintenance of blood-brain barrier integrity\",\n        \"Prevention of pathological cell migration and invasion\",\n        \"Establishment of glial-glial networks with proper spacing and communication\"\n      ],\n      \"evidence_summary\": \"The glial cell adhesion program represents the structural architecture that organizes the nervous system into functional compartments and establishes the critical intercellular contacts that support neuronal function. The presence of multiple independent adhesion systems (desmosomal, classical cadherin, CAM, claudin, and nodal adhesion proteins) indicates multiple redundant mechanisms ensuring robust adhesion. In normal CNS, this multi-layered adhesion system maintains proper cellular relationships and prevents inappropriate cell migration. In astrocytoma context, adhesion molecules are frequently downregulated, contributing to loss of contact inhibition, enhanced cell migration and invasion, and disruption of normal glial-neuronal relationships. Studies of high-grade gliomas consistently show reduced expression of adhesion proteins including cadherins, claudins, and CAMs, which enables tumor cells to escape their tissue context and promotes invasive behavior.\",\n      \"significance_score\": 0.91,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Comprehensive characterization of adhesion proteins in CNS development and mature tissue\"\n        },\n        {\n          \"source_id\": \"26\",\n          \"notes\": \"Cadherin and claudin expression in oligodendrocyte development\"\n        },\n        {\n          \"source_id\": \"1\",\n          \"notes\": \"Adhesion molecules in axon-glial interactions\"\n        },\n        {\n          \"source_id\": \"16\",\n          \"notes\": \"Altered adhesion protein expression following CNS injury\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"PKP4\",\n        \"PCDH7\",\n        \"CDH19\",\n        \"CADM1\",\n        \"CADM2\",\n        \"CLDN11\",\n        \"NFASC\",\n        \"MAG\",\n        \"MOG\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"NCAM1\",\n          \"NCAM2\",\n          \"L1CAM\",\n          \"CONTACTIN\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Additional adhesion molecules in glial-neuronal interactions\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Semaphorin-Plexin Axon Guidance Signaling\",\n      \"description\": \"Extracellular signaling system mediating repulsive and attractive guidance cues that establish proper neural circuit architecture and maintain appropriate axon-glial relationships. SEMA3E, SEMA4D, SEMA5A, and SEMA5B represent a family of secreted and membrane-bound ligands that signal through plexin and neuropilin receptors on responding cells. SEMA4D is expressed on oligodendrocytes and functions as a growth inhibitory signal preventing axon overgrowth. SEMA3E and SEMA5A function as chemorepellents during axon guidance. These semaphorins signal through plexin receptors which activate downstream Rho GTPase signaling cascades. The semaphorin-Rho signaling axis dynamically remodels the cytoskeleton to produce morphological changes and altered migratory behavior.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Semaphorin-plexin signal transduction\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"Ephrin-Eph signaling parallel to semaphorin-plexin axes in neural signaling\"\n            },\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Semaphorin signaling in axon guidance and glial development\"\n            },\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"SEMA4D as oligodendrocyte-expressed growth inhibitor\"\n            }\n          ],\n          \"genes\": [\n            \"SEMA3E\",\n            \"SEMA4D\",\n            \"SEMA5A\",\n            \"SEMA5B\"\n          ]\n        },\n        {\n          \"name\": \"Axon guidance and pathfinding\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"Axon guidance mechanisms including semaphorin signaling\"\n            },\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Semaphorins in establishing proper neural circuit architecture\"\n            }\n          ],\n          \"genes\": [\n            \"SEMA3E\",\n            \"SEMA5A\",\n            \"SEMA5B\",\n            \"NTN1\",\n            \"SEMA6D\"\n          ]\n        },\n        {\n          \"name\": \"Oligodendrocyte-axon spacing regulation\",\n          \"citations\": [\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"SEMA4D-mediated inhibition of axon overgrowth within myelinated regions\"\n            },\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"SEMA4D in maintaining proper myelin thickness\"\n            }\n          ],\n          \"genes\": [\n            \"SEMA4D\",\n            \"MAG\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Semaphorin ligand family\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Diverse semaphorin family members in CNS guidance\"\n            }\n          ],\n          \"genes\": [\n            \"SEMA3E\",\n            \"SEMA4D\",\n            \"SEMA5A\",\n            \"SEMA5B\",\n            \"SEMA6D\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Repulsion of axons from oligodendrocyte processes during development and maintenance of established myelination patterns\",\n        \"Prevention of aberrant axon growth within myelinated regions\",\n        \"Dynamically adjustable oligodendrocyte morphology in response to local axonal signals\",\n        \"Integration of multiple guidance cues to establish proper neural circuit topology\",\n        \"Maintenance of appropriate spacing between axons and glial processes\"\n      ],\n      \"evidence_summary\": \"The semaphorin-plexin signaling program provides cell-cell communication mechanisms that allow oligodendrocytes to sense and respond to the axonal environment, and allow axons to respond to glial signals. Semaphorin ligands are secreted or membrane-tethered proteins that signal at cell-cell contacts or over short distances, making them ideal for local circuit organization. SEMA4D expression on oligodendrocytes creates a biochemical boundary that discourages excessive axon growth within myelinating regions, helping to maintain appropriate g-ratios (ratio of axon diameter to myelinated fiber diameter). In astrocytoma context, semaphorin signaling is often dysregulated, with altered semaphorin and plexin expression contributing to aberrant axon-tumor cell interactions and disrupted neural circuit function. Additionally, semaphorin signaling plays roles in immune cell migration and interaction with tumor cells, contributing to the immunological landscape of glioblastomas.\",\n      \"significance_score\": 0.85,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Comprehensive analysis of semaphorin-plexin signaling in CNS development and glial interactions\"\n        },\n        {\n          \"source_id\": \"13\",\n          \"notes\": \"Ephrin-Eph and related guidance signaling in neural circuits\"\n        },\n        {\n          \"source_id\": \"1\",\n          \"notes\": \"SEMA4D expressed on oligodendrocytes as axon growth inhibitor\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"SEMA3E\",\n        \"SEMA4D\",\n        \"SEMA5A\",\n        \"SEMA5B\",\n        \"SEMA6D\",\n        \"NTN1\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"PLXNA1\",\n          \"PLXNA2\",\n          \"PLXND1\",\n          \"NRP1\",\n          \"NRP2\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Plexin and neuropilin receptors as semaphorin signal transducers\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Rho GTPase Signaling and Cytoskeletal Dynamics\",\n      \"description\": \"Coordinated signaling system regulating Rho family GTPase (RhoA, Rac1, Cdc42) activation and downstream cytoskeletal remodeling. GEFs (guanine nucleotide exchange factors) including ARFGEF3, RASGEF1B, and RAPGEF1 promote GDP-GTP exchange to activate Rho GTPases. GAPs (GTPase-activating proteins) including ARHGAP5 and ARHGAP31 promote GTP hydrolysis to inactivate Rho GTPases. Downstream effector proteins including SHROOM4 (links Rho signaling to actomyosin dynamics), ADD3 (links Rho signaling to actin polymerization), and FRMD proteins mediate focal adhesion dynamics. This integrated program dynamically remodels actin and microtubule cytoskeletons in response to external signals, enabling cell morphological changes, migration, and process outgrowth.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Rho GTPase activation by GEFs\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"GEF-mediated Rho GTPase activation in cell morphology and migration\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Rho signaling in glial cell differentiation\"\n            }\n          ],\n          \"genes\": [\n            \"ARFGEF3\",\n            \"RASGEF1B\",\n            \"RAPGEF1\"\n          ]\n        },\n        {\n          \"name\": \"Rho GTPase inactivation by GAPs\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"GAP-mediated Rho GTPase inactivation\"\n            }\n          ],\n          \"genes\": [\n            \"ARHGAP5\",\n            \"ARHGAP31\"\n          ]\n        },\n        {\n          \"name\": \"Actomyosin dynamics and stress fiber formation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"SHROOM proteins in controlling actomyosin contractility\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Cytoskeletal dynamics in oligodendrocyte process extension\"\n            }\n          ],\n          \"genes\": [\n            \"SHROOM4\",\n            \"ADD3\",\n            \"FRMD5\",\n            \"FRMD4B\",\n            \"FRMD4A\"\n          ]\n        },\n        {\n          \"name\": \"Focal adhesion assembly and disassembly\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"FRMD proteins in focal adhesion dynamics\"\n            }\n          ],\n          \"genes\": [\n            \"FRMD5\",\n            \"FRMD4B\",\n            \"FRMD4A\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Rho GTPase regulatory complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"GEF and GAP proteins as Rho regulators\"\n            }\n          ],\n          \"genes\": [\n            \"ARFGEF3\",\n            \"RASGEF1B\",\n            \"RAPGEF1\",\n            \"ARHGAP5\",\n            \"ARHGAP31\"\n          ]\n        },\n        {\n          \"name\": \"Actomyosin contractile apparatus\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"SHROOM-mediated organization of actomyosin\"\n            }\n          ],\n          \"genes\": [\n            \"SHROOM4\",\n            \"ADD3\"\n          ]\n        },\n        {\n          \"name\": \"Focal adhesion complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"FRMD proteins as FAK-associated focal adhesion regulators\"\n            }\n          ],\n          \"genes\": [\n            \"FRMD5\",\n            \"FRMD4B\",\n            \"FRMD4A\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Dynamic remodeling of actin cytoskeleton in response to environmental cues\",\n        \"Rapid transition between exploratory and retracted cell morphology\",\n        \"Enhanced migratory capacity and process extension\",\n        \"Responsive adjustment of focal adhesions at cell-substrate interface\",\n        \"Integration of multiple guidance signals into coordinated cytoskeletal response\"\n      ],\n      \"evidence_summary\": \"The Rho GTPase signaling program represents one of the most fundamental and extensively interconnected cytoskeletal regulatory systems in cells. Rho family GTPases (RhoA, Rac1, Cdc42) serve as molecular switches that transduce extracellular signals into cytoskeletal rearrangements, and are regulated by a large family of GEFs and GAPs that provide signal specificity and spatial localization. The presence of multiple GEFs, multiple GAPs, and multiple downstream effectors in the input gene list indicates a high capacity for dynamic cytoskeletal remodeling in response to environmental signals. In oligodendrocytes, Rho signaling controls process outgrowth and retraction, allowing individual oligodendrocytes to dynamically adjust their morphology as they extend processes along multiple axons. In astrocytoma context, Rho signaling is typically enhanced in tumor cells, contributing to their increased motility and invasiveness, while simultaneously altered Rho signaling in tumor-associated oligodendrocytes might contribute to their reduced myelinating capacity and altered responses to the tumor microenvironment.\",\n      \"significance_score\": 0.88,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Comprehensive analysis of Rho GTPase signaling in CNS development and glial cell dynamics\"\n        },\n        {\n          \"source_id\": \"26\",\n          \"notes\": \"Rho signaling in oligodendrocyte differentiation and process extension\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"ARFGEF3\",\n        \"RASGEF1B\",\n        \"RAPGEF1\",\n        \"ARHGAP5\",\n        \"ARHGAP31\",\n        \"SHROOM4\",\n        \"ADD3\",\n        \"FRMD5\",\n        \"FRMD4B\",\n        \"FRMD4A\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"RHOA\",\n          \"RAC1\",\n          \"CDC42\",\n          \"SRF\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Core Rho GTPases and downstream transcriptional regulators\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"DOCK Family Cytoskeletal Remodeling\",\n      \"description\": \"Specialized subset of GEFs specifically activating Rac1 and Cdc42 (but not RhoA) through direct catalytic mechanism distinct from Dbl-family GEFs. DOCK4, DOCK6, and DOCK10 collectively represent this program. DOCK family members are characterized by large catalytic domains and specific interactions with regulatory proteins and particular Rho family GTPases. Functionally, DOCK-mediated signaling tends to drive processes associated with cell migration, process extension, and exploratory morphology rather than contractile stress fiber formation. DOCK6 has been specifically implicated in oligodendrocyte process outgrowth and establishment of appropriate oligodendrocyte-axon spacing during myelinogenesis. Multiple DOCK members likely provide redundancy and allow fine-tuned regulation of Rac and Cdc42 in different cellular contexts.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Rac1 and Cdc42 activation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"DOCK family proteins as specific Rac/Cdc42 activators\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Rac signaling in oligodendrocyte process dynamics\"\n            }\n          ],\n          \"genes\": [\n            \"DOCK4\",\n            \"DOCK6\",\n            \"DOCK10\"\n          ]\n        },\n        {\n          \"name\": \"Cell process extension and outgrowth\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"DOCK6 role in oligodendrocyte process extension\"\n            }\n          ],\n          \"genes\": [\n            \"DOCK4\",\n            \"DOCK6\"\n          ]\n        },\n        {\n          \"name\": \"Immune cell migration\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"DOCK10 function in immune cell migratory responses\"\n            }\n          ],\n          \"genes\": [\n            \"DOCK10\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"DOCK GEF complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"DOCK family as specialized GEF subfamily\"\n            }\n          ],\n          \"genes\": [\n            \"DOCK4\",\n            \"DOCK6\",\n            \"DOCK10\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Preferential activation of lamellipodial and filopodial protrusion over stress fiber formation\",\n        \"Enhanced oligodendrocyte process outgrowth and exploratory morphology\",\n        \"Dynamic process extension along multiple axons\",\n        \"Responsive adjustment of process branching and spacing\",\n        \"Enhanced migratory and invasive capacity in transformed cells\"\n      ],\n      \"evidence_summary\": \"DOCK family proteins represent a specialized GEF subfamily that functions distinctly from the classical Dbl-family GEFs in producing a bias toward Rac1/Cdc42 activation rather than RhoA activation. This functional distinction has important consequences: RhoA activation promotes stress fiber formation and contractility, whereas Rac1/Cdc42 activation promotes lamellipodial and filopodial protrusion. In oligodendrocytes, DOCK-mediated Rac activation drives process outgrowth and the dynamic adjustment of process morphology needed for myelinating up to 50 axonal segments. DOCK proteins also function in immune cell migration, particularly in dendritic cells and lymphocytes, suggesting this program may interface with immune responses in the tumor microenvironment. In astrocytoma context, enhanced DOCK-mediated signaling would promote invasive migration of both tumor cells and potentially immune cells, while altered DOCK signaling in tumor-associated oligodendrocytes might contribute to their reduced myelinating capacity.\",\n      \"significance_score\": 0.80,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"DOCK6 and DOCK family proteins in cell morphology and process dynamics\"\n        },\n        {\n          \"source_id\": \"26\",\n          \"notes\": \"DOCK signaling in oligodendrocyte development\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"DOCK4\",\n        \"DOCK6\",\n        \"DOCK10\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"ELMO1\",\n          \"ELMO2\",\n          \"ELMO3\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"ELMO proteins as regulatory partners of DOCK GEFs\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Phospholipase Signaling and Lipid Second Messengers\",\n      \"description\": \"Coordinated phospholipid signaling system generating lipid second messengers that regulate calcium mobilization, kinase activation, and metabolic state. PLCB1 hydrolyzes PIP2 to generate IP3 and DAG, mobilizing calcium from intracellular stores and activating PKC. PLD1 catalyzes hydrolysis of phosphatidylcholine to generate phosphatidic acid, a lipid second messenger regulating mTOR signaling and metabolic processes. GNB4 and GNAI1 encode G protein components that activate PLCB1 downstream of G-protein-coupled receptors. PRKCE encodes PKC epsilon, a major effector of PLCB1-generated DAG. The kinase cascade initiated by phospholipase signaling includes multiple serine/threonine and tyrosine kinases that phosphorylate diverse substrates including ion channels, transcription factors, and structural proteins.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"GPCR-PLC-IP3 calcium signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"G protein-coupled receptor activation of phospholipase C\"\n            },\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"Calcium signaling downstream of activated astrocytes\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Calcium mobilization in glial cell differentiation\"\n            }\n          ],\n          \"genes\": [\n            \"GNAI1\",\n            \"GNB4\",\n            \"PLCB1\",\n            \"ITPR2\"\n          ]\n        },\n        {\n          \"name\": \"PKC-mediated protein phosphorylation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"PKC epsilon downstream of DAG generation\"\n            }\n          ],\n          \"genes\": [\n            \"PRKCE\"\n          ]\n        },\n        {\n          \"name\": \"Phosphatidic acid-mTOR signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"PLD1-mediated phosphatidic acid generation in metabolic signaling\"\n            }\n          ],\n          \"genes\": [\n            \"PLD1\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Phospholipase signaling complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"PLCB1 and associated G proteins in signal transduction\"\n            }\n          ],\n          \"genes\": [\n            \"PLCB1\",\n            \"GNAI1\",\n            \"GNB4\",\n            \"PRKCE\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Rapid calcium mobilization in response to extracellular signals\",\n        \"PKC-mediated phosphorylation of downstream targets\",\n        \"Integration of neurotransmitter and growth factor signals\",\n        \"Metabolic reprogramming through phosphatidic acid-mTOR signaling\",\n        \"Coupling of energy state to gene expression and cell proliferation\"\n      ],\n      \"evidence_summary\": \"Phospholipase signaling represents a central hub that integrates multiple extracellular signals into coordinated intracellular responses. GPCR activation of heterotrimeric G proteins leads to PLC-mediated generation of two lipid second messengers (IP3 and DAG) that activate complementary pathways: IP3 mobilizes calcium through ITPR2, while DAG activates PKC. Additionally, PLD1-mediated generation of phosphatidic acid serves as a direct activator of mTOR signaling and nutrient sensing. In oligodendrocytes, this signaling program allows responses to neurotransmitters, growth factors, and metabolic status. The presence of complete GPCR-G protein-PLCB1-PKC cascade components indicates robust capacity for signal integration. In astrocytoma context, enhanced phospholipase signaling contributes to the constitutive growth signaling and altered metabolic state characteristic of tumor cells.\",\n      \"significance_score\": 0.82,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Phospholipase C and G protein signaling in nervous system development\"\n        },\n        {\n          \"source_id\": \"16\",\n          \"notes\": \"Calcium signaling in astrocyte responses\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"PLCB1\",\n        \"PLD1\",\n        \"PRKCE\",\n        \"GNAI1\",\n        \"GNB4\",\n        \"ITPR2\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"GPCR\",\n          \"GNA12\",\n          \"PRKCA\",\n          \"PRKCB\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Broader G protein and PKC family members in phospholipase signaling\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Ion Channel Regulation and Neuronal Excitability Interface\",\n      \"description\": \"Coordinated expression of ion channels that regulate cellular excitability and calcium homeostasis in oligodendrocytes. KCNS3 encodes voltage-gated potassium channel that contributes to outward potassium currents and influences cellular excitability. P2RX7 encodes purinergic ATP-gated ion channel mediating calcium influx in response to extracellular ATP and functioning in innate immune signaling. GLRA3 encodes glycine receptor subunit mediating responses to glycine and inhibitory neurotransmission. ITPR2 encodes IP3 receptor mediating store-operated calcium release. These four genes collectively represent major routes for calcium entry into oligodendrocytes. Precise calcium homeostasis is critical for oligodendrocyte health and function, as both excessive and deficient calcium signaling can trigger apoptosis.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Voltage-gated potassium channel function\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Potassium channel expression in oligodendrocytes\"\n            },\n            {\n              \"source_id\": \"26\",\n              \"notes\": \"Ion channel regulation of oligodendrocyte excitability\"\n            }\n          ],\n          \"genes\": [\n            \"KCNS3\"\n          ]\n        },\n        {\n          \"name\": \"Purinergic ATP signaling and calcium influx\",\n          \"citations\": [\n            {\n              \"source_id\": \"32\",\n              \"notes\": \"P2RX7 role in complement-mediated cytotoxicity\"\n            }\n          ],\n          \"genes\": [\n            \"P2RX7\"\n          ]\n        },\n        {\n          \"name\": \"Glycine receptor signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"Inhibitory neurotransmission and glial responses\"\n            },\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"Glycine receptor in neuronal-glial signaling\"\n            }\n          ],\n          \"genes\": [\n            \"GLRA3\"\n          ]\n        },\n        {\n          \"name\": \"IP3-mediated calcium release\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"ITPR2 in store-operated calcium signaling\"\n            }\n          ],\n          \"genes\": [\n            \"ITPR2\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Ion channel complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Diverse ion channel types in oligodendrocytes\"\n            }\n          ],\n          \"genes\": [\n            \"KCNS3\",\n            \"P2RX7\",\n            \"GLRA3\",\n            \"ITPR2\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Regulated cellular excitability through potassium efflux\",\n        \"Calcium influx in response to extracellular ATP and immune signals\",\n        \"Response to inhibitory neurotransmitters through glycine receptors\",\n        \"Calcium homeostasis through store-operated and IP3-mediated release\",\n        \"Integration of multiple excitatory and inhibitory signals\"\n      ],\n      \"evidence_summary\": \"Ion channels in oligodendrocytes provide multiple mechanisms for sensing the extracellular environment and regulating calcium homeostasis, which is critical for cell survival and function. Unlike neurons, oligodendrocytes have non-excitable membranes and do not generate action potentials, but they express diverse ion channels that regulate resting membrane potential and calcium signaling. The presence of multiple calcium entry routes (KCNS3-mediated depolarization allowing voltage-gated calcium entry, P2RX7-mediated ATP response, GLRA3 glycine response) indicates robust capacity for calcium mobilization in response to various signals. However, excessive or prolonged calcium elevation leads to calcium toxicity and cell death, making tight regulation of calcium crucial. In astrocytoma context, altered ion channel expression and calcium signaling in tumor-associated oligodendrocytes may contribute to their dysfunction, while simultaneously altered calcium signaling in tumor cells contributes to their transformed phenotype and responsiveness to growth factors.\",\n      \"significance_score\": 0.78,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Ion channel expression and function in oligodendrocytes\"\n        },\n        {\n          \"source_id\": \"32\",\n          \"notes\": \"P2RX7 in complement-mediated immune responses\"\n        },\n        {\n          \"source_id\": \"16\",\n          \"notes\": \"Calcium signaling in glial cells\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"KCNS3\",\n        \"P2RX7\",\n        \"GLRA3\",\n        \"ITPR2\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"CACNA1C\",\n          \"CACNB3\",\n          \"ATP2A2\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Voltage-gated calcium channels and calcium-ATPases in calcium homeostasis\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Protein Tyrosine and Serine/Threonine Kinase Signaling\",\n      \"description\": \"Integrated signaling cascade integrating extracellular signals through tyrosine and serine/threonine phosphorylation of downstream targets. FYN encodes Src family tyrosine kinase mediating signaling downstream of RTKs and adhesion molecules with roles in axon-glial signaling and myelination. AATK encodes apoptosis-associated tyrosine kinase functioning in calcium-dependent signaling and neuronal differentiation. SGK1 encodes serum- and glucocorticoid-regulated kinase 1 phosphorylating ion channels and stress response substrates. PRKCE encodes PKC epsilon, serine/threonine kinase activated by DAG from phospholipase signaling. PPP2R2B encodes regulatory subunit of PP2A phosphatase, which dephosphorylates downstream targets and serves as major brake on kinase signaling. This coordinated kinase-phosphatase network dynamically phosphorylates numerous substrates controlling cell differentiation, migration, and metabolic state.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Tyrosine kinase signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"Tyrosine kinase signaling in glutamatergic neurons downstream of Eph receptors\"\n            },\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"FYN-mediated signaling in glial development\"\n            }\n          ],\n          \"genes\": [\n            \"FYN\",\n            \"AATK\"\n          ]\n        },\n        {\n          \"name\": \"Serine/threonine kinase signaling\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"PKC and SGK signaling in glial cells\"\n            }\n          ],\n          \"genes\": [\n            \"PRKCE\",\n            \"SGK1\"\n          ]\n        },\n        {\n          \"name\": \"Protein phosphatase 2A-mediated dephosphorylation\",\n          \"citations\": [\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"PP2A subunits in regulating phosphorylation cascades\"\n            },\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"PP2A-B subunits in phosphorylation control\"\n            }\n          ],\n          \"genes\": [\n            \"PPP2R2B\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Tyrosine kinase complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"13\",\n              \"notes\": \"Tyrosine kinase family members in signal transduction\"\n            }\n          ],\n          \"genes\": [\n            \"FYN\",\n            \"AATK\"\n          ]\n        },\n        {\n          \"name\": \"Serine/threonine kinase complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"PKC family and related kinases in second messenger signaling\"\n            }\n          ],\n          \"genes\": [\n            \"PRKCE\",\n            \"SGK1\"\n          ]\n        },\n        {\n          \"name\": \"Protein phosphatase 2A regulatory complex\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"PP2A as major serine/threonine phosphatase\"\n            }\n          ],\n          \"genes\": [\n            \"PPP2R2B\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Integration of receptor tyrosine kinase and adhesion signals\",\n        \"Phosphorylation-based regulation of protein function and localization\",\n        \"Stress-responsive kinase activation through SGK1\",\n        \"Balanced kinase-phosphatase activity maintaining dynamic equilibrium\",\n        \"Responsive adjustment of differentiation, migration, and metabolic state\"\n      ],\n      \"evidence_summary\": \"Protein phosphorylation represents one of the most extensively interconnected signaling networks in cells, with thousands of potential kinase-substrate pairs providing nearly unlimited specificity and dynamic regulation. FYN, as a Src family kinase, functions downstream of multiple receptor systems including RTKs, integrins, and immune receptors, making it a convergence point for multiple extracellular signals. SGK1 functions as a nutrient and stress sensor, being activated in response to serum, glucocorticoids, and osmotic stress, making it important for metabolic integration. The presence of PPP2R2B (PP2A regulatory subunit) indicates existence of a major phosphatase that can dephosphorylate and inactivate kinase signaling, establishing feedback control. In oligodendrocytes, this kinase-phosphatase program is essential for integrating differentiation signals during development and responding to injury and inflammatory signals in disease. In astrocytoma context, the kinase signaling landscape is dramatically altered, with many tumors showing constitutive activation of growth-promoting kinases.\",\n      \"significance_score\": 0.83,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Kinase signaling in glial cell development and function\"\n        },\n        {\n          \"source_id\": \"13\",\n          \"notes\": \"Tyrosine kinase signaling in neural physiology\"\n        },\n        {\n          \"source_id\": \"16\",\n          \"notes\": \"Phosphorylation cascades in astrocyte responses\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"FYN\",\n        \"AATK\",\n        \"PRKCE\",\n        \"SGK1\",\n        \"PPP2R2B\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"SRC\",\n          \"LYN\",\n          \"YES\",\n          \"PKA\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Related tyrosine kinases and cAMP-dependent protein kinase in CNS signaling\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Extracellular Matrix Organization and Remodeling\",\n      \"description\": \"Coordinated production and modification of extracellular matrix components creating structural support and providing cell-matrix signaling interfaces. ACAN encodes aggrecan, large proteoglycan particularly abundant in perineuronal nets (PNNs) that regulate synaptic plasticity and stability. TNR encodes tenascin R, ECM glycoprotein contributing to PNN structural integrity and modulating neural plasticity. NTN1 encodes netrin-1, functioning as both axon guidance molecule and ECM-associated protein. SMOC1 encodes secreted modular calcium-binding protein, ECM component regulating cell-matrix interactions. ADAMTS14 encodes metallopeptidase cleaving ECM proteins during tissue remodeling. These ECM components are particularly enriched around neurons receiving strong inhibitory inputs and in regions of activity-dependent refinement. The ECM program collectively organizes perineuronal nets, glial scars, and tissue architecture.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Perineuronal net assembly and maintenance\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Aggrecan and tenascin R in perineuronal net structure\"\n            },\n            {\n              \"source_id\": \"1\",\n              \"notes\": \"ECM molecules in synaptic plasticity and stabilization\"\n            }\n          ],\n          \"genes\": [\n            \"ACAN\",\n            \"TNR\",\n            \"NTN1\",\n            \"SMOC1\"\n          ]\n        },\n        {\n          \"name\": \"ECM proteolysis and remodeling\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"ADAMTS metallopeptidases in ECM remodeling\"\n            }\n          ],\n          \"genes\": [\n            \"ADAMTS14\"\n          ]\n        },\n        {\n          \"name\": \"Axon guidance through ECM\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Netrin-1 as both ligand and ECM component\"\n            }\n          ],\n          \"genes\": [\n            \"NTN1\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Perineuronal net structure\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"PNN composed of proteoglycans, glycoproteins, and ECM proteins\"\n            }\n          ],\n          \"genes\": [\n            \"ACAN\",\n            \"TNR\",\n            \"NTN1\",\n            \"SMOC1\"\n          ]\n        },\n        {\n          \"name\": \"ECM-modifying enzyme\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"ADAMTS proteases in ECM proteolysis\"\n            }\n          ],\n          \"genes\": [\n            \"ADAMTS14\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Organization of perineuronal nets surrounding stabilized neuronal populations\",\n        \"Regulation of synaptic plasticity through ECM stabilization\",\n        \"Structural support for glial-neuronal networks\",\n        \"Controlled ECM remodeling during development and injury\",\n        \"Cell-matrix signaling providing positional and developmental cues\"\n      ],\n      \"evidence_summary\": \"The extracellular matrix represents a dynamic tissue component that extends beyond simple structural support to provide complex signaling information and regulate cellular behavior. Perineuronal nets, specialized ECM structures surrounding certain neurons, have emerged as critical regulators of synaptic plasticity and critical periods of development. ACAN and TNR represent the core structural components of PNNs, which are particularly abundant around parvalbumin-positive inhibitory interneurons in cerebral cortex and other regions. The presence of netrin-1 (NTN1) indicates an integration of axon guidance signaling with ECM organization. In the tumor microenvironment, ECM organization is dramatically altered, with both excessive ECM deposition (leading to desmoplastic reactions) and degradation (creating permissive invasion conditions). The presence of ADAMTS14, a potent ECM protease, suggests capacity for matrix remodeling that could facilitate either tumor invasion or tissue repair depending on context.\",\n      \"significance_score\": 0.76,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Comprehensive analysis of ECM organization in CNS development including perineuronal nets\"\n        },\n        {\n          \"source_id\": \"1\",\n          \"notes\": \"ECM in synaptic plasticity and neural circuit refinement\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"ACAN\",\n        \"TNR\",\n        \"NTN1\",\n        \"SMOC1\",\n        \"ADAMTS14\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"BREVICAN\",\n          \"NEUROCAN\",\n          \"VERSICAN\",\n          \"LINK PROTEIN\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Additional proteoglycans and link proteins in perineuronal net assembly\"\n          }\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Autophagy, Protein Quality Control, and Cellular Stress Response\",\n      \"description\": \"Coordinated system for selective protein degradation, damaged organelle removal, and cellular stress adaptation ensuring oligodendrocyte survival under normal and stress conditions. TFEB encodes transcription factor EB that regulates genes involved in lysosomal function, autophagy, and cellular stress responses, serving as master regulator of lysosomal biogenesis. TRIM2 and RNF144A encode ubiquitin ligases mediating selective ubiquitination of protein substrates targeting them for proteasomal or autophagy-mediated degradation. UST encodes ubiquitin-specific peptidase removing ubiquitin modifications from substrates. These autophagy and proteolysis genes ensure oligodendrocytes can respond to cellular stress by initiating protein degradation, removing damaged components, and restoring homeostasis. This program is particularly activated during oxidative stress, energy depletion, and inflammatory challenge characteristic of tumor microenvironment.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Lysosomal biogenesis and autophagy initiation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"TFEB as master regulator of lysosomal genes\"\n            },\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"Lysosomal dysfunction in chronic TBI\"\n            }\n          ],\n          \"genes\": [\n            \"TFEB\"\n          ]\n        },\n        {\n          \"name\": \"Selective protein ubiquitination for degradation\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"E3 ubiquitin ligases in selective protein degradation\"\n            }\n          ],\n          \"genes\": [\n            \"TRIM2\",\n            \"RNF144A\"\n          ]\n        },\n        {\n          \"name\": \"Deubiquitination and ubiquitin recycling\",\n          \"citations\": [\n            {\n              \"source_id\": \"16\",\n              \"notes\": \"Ubiquitin-specific peptidases in protein quality control\"\n            }\n          ],\n          \"genes\": [\n            \"UST\"\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Ubiquitin proteasome system\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"E3 ligases and ubiquitin cascade in protein degradation\"\n            }\n          ],\n          \"genes\": [\n            \"TRIM2\",\n            \"RNF144A\",\n            \"UST\"\n          ]\n        },\n        {\n          \"name\": \"Lysosomal autophagy machinery\",\n          \"citations\": [\n            {\n              \"source_id\": \"25\",\n              \"notes\": \"Lysosomal biogenesis controlled by TFEB\"\n            }\n          ],\n          \"genes\": [\n            \"TFEB\"\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Rapid clearance of misfolded or damaged proteins\",\n        \"Removal of damaged mitochondria and organelles through mitophagy and autophagy\",\n        \"Restoration of cellular homeostasis after oxidative or energetic stress\",\n        \"Prevention of protein aggregation and cellular dysfunction\",\n        \"Enhanced survival of oligodendrocytes in tumor microenvironment stress\"\n      ],\n      \"evidence_summary\": \"Protein quality control systems, including the ubiquitin-proteasome system and autophagy-lysosome system, are essential for cell survival during stress conditions. TFEB serves as a master regulator of these systems, being activated in response to stress signals and upregulating the genes encoding lysosomal enzymes and autophagy machinery. The presence of TFEB alongside TRIM2 and RNF144A (ubiquitin ligases) and UST (deubiquitinase) indicates a complete capacity for targeted protein degradation. In oligodendrocytes, which are particularly metabolically active cells due to continuous myelin synthesis and maintenance, these protein quality control systems are essential. In astrocytoma context, tumor cells often show altered autophagy, with both increased autophagy in some contexts (supporting cell survival under metabolic stress) and decreased autophagy in others, while simultaneously the tumor microenvironment stress (hypoxia, nutrient deprivation, inflammation) triggers autophagy in surrounding cells including oligodendrocytes. Enhanced autophagy in tumor-associated oligodendrocytes might represent attempted adaptation to stress but could also contribute to their progressive dysfunction and death.\",\n      \"significance_score\": 0.75,\n      \"citations\": [\n        {\n          \"source_id\": \"25\",\n          \"notes\": \"Lysosomal biogenesis and autophagy in glial cell stress responses\"\n        },\n        {\n          \"source_id\": \"16\",\n          \"notes\": \"Autophagy and protein quality control in chronic pathological conditions\"\n        }\n      ],\n      \"supporting_genes\": [\n        \"TFEB\",\n        \"TRIM2\",\n        \"RNF144A\",\n        \"UST\"\n      ],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\n          \"ATG7\",\n          \"ATG12\",\n          \"LC3\",\n          \"SQSTM1\"\n        ],\n        \"citations\": [\n          {\n            \"source_id\": \"25\",\n            \"notes\": \"Core autophagy machinery genes required for functional autophagy\"\n          }\n        ]\n      }\n    }\n  ],\n  \"method\": {\n    \"clustering_basis\": [\n      \"Functional annotations from literature describing oligodendrocyte development, myelination, and glial cell biology\",\n      \"Gene ontology enrichment for biological processes related to myelin formation, cell adhesion, axon-glial interactions\",\n      \"Known protein complexes and signaling cascades from pathway databases\",\n      \"Single-cell transcriptomic studies identifying cell-type-specific gene programs\",\n      \"Clinical and basic neuroscience literature on astrocytoma microenvironment and glial dysfunction\"\n    ],\n    \"notes\": \"Analysis prioritized well-established oligodendrocyte functions with strong multi-study consensus, while contextualizing findings within astrocytoma biology where oligodendrocyte function is typically compromised. The input gene list is substantially enriched for markers of mature oligodendrocytes and OPCs, suggesting origin from transcriptomic analysis of glioma tissue or oligodendrocyte-enriched brain regions.\"\n  },\n  \"version\": \"1.0\"\n}\n```\n\n## Interpreting Gene Programs in Astrocytoma: Clinical and Therapeutic Implications\n\nThe twelve gene programs identified in this analysis collectively paint a portrait of oligodendrocyte function in normal CNS and highlight the alterations that occur when these cells are embedded in the astrocytoma microenvironment. Understanding these programs provides crucial context for interpreting astrocytoma pathophysiology and identifying potential therapeutic targets. The oligodendrocyte transcriptional specification program represents the master control system that locks cells into the glial fate and enables all downstream differentiation steps. When this program is disrupted in astrocytoma, either directly through mutation of transcription factors or indirectly through inflammatory signals that antagonize transcriptional regulators, the result is loss of oligodendrocyte identity and reduced capacity for myelination.\n\nThe myelin protein assembly and myelin lipid biosynthesis programs represent the most directly observable function of oligodendrocytes—the production of myelin. In healthy CNS tissue, these programs are constitutively active in mature oligodendrocytes, resulting in massive ongoing production of MBP, PLP1, lipids, and other myelin components. In astrocytoma-affected tissue, these programs are typically suppressed, leading to progressive demyelination and loss of myelin integrity. This demyelination has multiple consequences: first, demyelinated axons conduct action potentials more slowly and with higher metabolic cost; second, demyelination exposes axons to increased oxidative stress and physical damage; third, the loss of myelin-derived metabolic support from oligodendrocytes leads to axonal energy depletion and dysfunction.\n\nThe glial cell adhesion program represents the structural architecture that maintains tissue organization and prevents aberrant cell migration. In astrocytoma, downregulation of adhesion molecules enables both tumor cell escape from their tissue context and disruption of normal glial-neuronal relationships. Additionally, intact adhesion molecules on tumor-adjacent oligodendrocytes might be actively disrupted by tumor-derived proteases or inflammatory mediators, further compromising tissue organization.\n\nThe semaphorin-plexin signaling and Rho GTPase programs represent the dynamic remodeling systems that allow cells to sense their environment and adjust morphology accordingly. In oligodendrocytes, these programs enable the precise extension and retraction of processes along multiple axons to achieve proper myelination. In astrocytoma, dysregulation of these programs contributes both to tumor cell invasion and to dysfunction of tumor-adjacent oligodendrocytes.\n\n## Concluding Synthesis: Gene Programs as Indicators of Tumor Microenvironment State and Therapeutic Opportunity\n\nThe comprehensive analysis of this 196-gene list within the astrocytoma context reveals a coherent biological narrative centered on oligodendrocyte biology and glial-neuronal interactions. The presence of this complete oligodendrocyte gene program in a context of astrocytoma suggests either that the tissue sample contained substantial populations of non-tumor oligodendrocytes, or that these genes represent a differentiation state that is dysregulated in tumor astrocytes or associated OPCs. The twelve identified gene programs collectively regulate the essential functions of oligodendrocytes: differentiation and fate specification, myelin protein and lipid synthesis, cell adhesion and tissue organization, axon-glial signaling and guidance, cytoskeletal dynamics and process extension, calcium and ionic homeostasis, phosphorylation-based signal integration, and stress response and cellular maintenance. In normal CNS, these programs function as an integrated system enabling oligodendrocytes to produce and maintain myelin while remaining responsive to their environment. In astrocytoma, dysregulation of these programs contributes to the pathophysiology of the disease, including demyelination, disrupted glial-neuronal interactions, altered immune responses, and ultimately neuronal dysfunction and cognitive decline in patients. Future therapeutic strategies targeting these programs could aim to either preserve oligodendrocyte function and myelin integrity in tumor-affected tissue, or exploit program dysregulation to specifically target tumor-associated glial cells while sparing normal oligodendrocytes. The detailed characterization of these gene programs, supported by comprehensive citation of foundational literature, provides a framework for such future investigations and therapeutic development.",
    "citations": [
      "https://www.nature.com/articles/s42003-025-09169-3",
      "https://www.nature.com/articles/s41698-025-01190-3",
      "https://www.ncbi.nlm.nih.gov/gene/18015",
      "https://www.ncbi.nlm.nih.gov/gene/546",
      "https://www.nature.com/articles/s41467-025-66109-9_reference.pdf",
      "https://www.nature.com/articles/s42003-025-09028-1",
      "https://www.ncbi.nlm.nih.gov/gene/8502",
      "https://www.ncbi.nlm.nih.gov/gene/20674",
      "https://www.nature.com/articles/s41593-025-02100-3",
      "https://www.ncbi.nlm.nih.gov/gene/5318",
      "https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=18508",
      "https://www.science.org/doi/10.1126/sciadv.adw7972",
      "https://www.ncbi.nlm.nih.gov/gene/121021",
      "https://www.ncbi.nlm.nih.gov/gene/13641",
      "https://www.nature.com/articles/s42003-025-09138-w",
      "https://www.ncbi.nlm.nih.gov/gene/10215",
      "https://www.ncbi.nlm.nih.gov/gene/7422",
      "https://www.ncbi.nlm.nih.gov/gene/2260",
      "https://www.ncbi.nlm.nih.gov/gene/4613",
      "https://www.ncbi.nlm.nih.gov/gene/4804",
      "https://www.nature.com/articles/s41421-025-00842-9",
      "https://www.ncbi.nlm.nih.gov/gene/7015",
      "https://www.nature.com/articles/s41593-025-02150-7",
      "https://www.ncbi.nlm.nih.gov/gene/21898",
      "https://www.ncbi.nlm.nih.gov/gene/12053",
      "https://www.ncbi.nlm.nih.gov/gene/18033",
      "https://www.nature.com/articles/s41467-025-66985-1",
      "https://www.nature.com/articles/s41598-025-27335-9",
      "https://www.ncbi.nlm.nih.gov/gene/6622",
      "https://www.ncbi.nlm.nih.gov/gene/5894",
      "https://www.ncbi.nlm.nih.gov/gene/2670",
      "http://json-schema.org/draft-07/schema#\","
    ],
    "duration_seconds": null
  },
  "report": {
    "context": {
      "cell_type": "Oligodendrocytes, Oligodendrocyte Progenitor Cells (OPCs), and Astrocytes",
      "disease": "Astrocytoma",
      "tissue": "Central Nervous System (CNS), brain"
    },
    "input_genes": [
      "LSAMP",
      "AC110285.1",
      "SSH2",
      "SLC44A1",
      "RASGEF1B",
      "RAPGEF1",
      "ENPP6",
      "EPB41L2",
      "PKP4",
      "BMPER",
      "PKP4-AS1",
      "PLCB1",
      "TMEM163",
      "TMEM132B",
      "TMEM108",
      "BCAS1",
      "GPR17",
      "AL359091.1",
      "SOX6",
      "PRKCE",
      "SRCIN1",
      "TF",
      "TCF7L2",
      "FYN",
      "PPP1R16B",
      "FRMD5",
      "FRMD4B",
      "FRMD4A",
      "APCDD1",
      "ACAN",
      "PCDH7",
      "SLC2A13",
      "SHROOM4",
      "SGCD",
      "SEMA4D",
      "AC006058.1",
      "AC008080.4",
      "SH3RF3",
      "MOG",
      "MPZL1",
      "ZEB2",
      "MVB12B",
      "MYRF",
      "LINC01170",
      "UGT8",
      "CLDN11",
      "NFASC",
      "SILC1",
      "CDK18",
      "TNS2",
      "TNS3",
      "KCNS3",
      "SIRT2",
      "AC079148.3",
      "CRB1",
      "LCNL1",
      "PRICKLE1",
      "DNM3",
      "FGF12",
      "FAM13C",
      "FA2H",
      "RNF144A",
      "CD22",
      "CNP",
      "CADM2",
      "SOX10",
      "GNAI1",
      "ST18",
      "PHYHIPL",
      "MBP",
      "MOB3B",
      "AC005042.2",
      "AC009041.2",
      "TUBB4A",
      "OPCML",
      "P2RX7",
      "TNR",
      "TNFRSF21",
      "PPP2R2B",
      "TMTC4",
      "PHACTR3",
      "SEMA5A",
      "ADRA1A",
      "PLD1",
      "PLP1",
      "TMEFF2",
      "GNB4",
      "MAG",
      "GLRA3",
      "SEMA5B",
      "FAM83D",
      "LIMS2",
      "PTGDS",
      "CPM",
      "NTN1",
      "GPC3",
      "PADI2",
      "DGKB",
      "PARD3B",
      "EPHB1",
      "KAZN",
      "DLG1",
      "DOCK10",
      "ITPR2",
      "PLEKHA6",
      "FAM102A",
      "PDE3B",
      "DOCK6",
      "DSCAM",
      "HDAC2-AS2",
      "DOCK4",
      "AATK",
      "SEMA6D",
      "SLC1A1",
      "AL512308.1",
      "TMOD1",
      "ADAM23",
      "AC098617.1",
      "AC092422.1",
      "AC069209.2",
      "SLC22A23",
      "TRIM2",
      "AC044781.1",
      "CADM1",
      "UST",
      "ZNF469",
      "ZNF488",
      "SGK1",
      "CENPJ",
      "LIMD1",
      "ZNF536",
      "SPNS2",
      "ARHGAP5-AS1",
      "ARFGEF3",
      "GALNT13",
      "TFEB",
      "GNG2",
      "AL136114.1",
      "GRID1",
      "ADD3",
      "ADAM33",
      "ADAMTS14",
      "AC024145.1",
      "ICK",
      "PCDH11Y",
      "IL1RAPL1",
      "KANK2",
      "FAM110C",
      "MDGA2",
      "KHDRBS3",
      "ZNF365",
      "ATCAY",
      "PPFIBP1",
      "SCARB1",
      "RGR",
      "SMOC1",
      "SEMA3E",
      "CCDC148",
      "EYS",
      "RINL",
      "PTPRO",
      "SLC7A14",
      "ELF1",
      "RBPJ",
      "EPS8",
      "DSCAML1",
      "RARB",
      "C12ORF40",
      "LGI3",
      "BEST1",
      "CDH19",
      "TMTC1",
      "TMEM235",
      "C10ORF90",
      "BRINP2",
      "SLC16A10",
      "OSBPL1A",
      "PDE4B",
      "E2F3",
      "NTM",
      "SLC7A14-AS1",
      "TNK2",
      "SLC24A2",
      "AC092969.1",
      "KLHL29",
      "AL157392.2",
      "NID2",
      "KIF21B",
      "ANKRD44",
      "BACH2",
      "ATP1B1",
      "MMP17",
      "PRKG2",
      "FERMT1",
      "PRIMA1",
      "ERBB3",
      "ARHGAP31",
      "FMNL2",
      "SYNDIG1",
      "ANO3"
    ],
    "programs": [
      {
        "program_name": "Oligodendrocyte Transcriptional Specification",
        "description": "Master regulatory program coordinating oligodendrocyte lineage commitment and differentiation through sequential activation of stage-specific transcription factors. SOX10 initiates oligodendroglial fate and maintains progenitor identity while promoting differentiation. MYRF amplifies and completes the mature oligodendrocyte transcriptional program. SOX6 refines mature oligodendrocyte identity and myelin gene expression. TCF7L2 serves as a co-factor in SOX-containing complexes that activate oligodendrocyte-specific genes. RBPJ mediates Notch signaling effects on oligodendrocyte differentiation. ZEB2 fine-tunes transcriptional networks through repression of alternative cell fate programs. TFEB regulates lysosomal and autophagy genes critical during cellular stress responses.",
        "atomic_biological_processes": [
          {
            "name": "Oligodendrocyte fate specification",
            "citations": [
              {
                "source_id": "25",
                "notes": "SOX10 as master regulator of oligodendrocyte development"
              },
              {
                "source_id": "26",
                "notes": "SOX10 and MYRF in oligodendrocyte differentiation trajectories"
              },
              {
                "source_id": "2",
                "notes": "TCF7L2 in oligodendrocyte specification networks"
              }
            ],
            "genes": [
              "SOX10",
              "MYRF",
              "SOX6",
              "TCF7L2",
              "RBPJ",
              "ZEB2",
              "TFEB"
            ],
            "ontology_id": "GO:0021778",
            "ontology_label": "oligodendrocyte cell fate specification",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "exact_match"
          },
          {
            "name": "Notch signaling in glial differentiation",
            "citations": [
              {
                "source_id": "20",
                "notes": "RBPJ downregulation promoting neurogenesis in astrocyte progenitors"
              },
              {
                "source_id": "30",
                "notes": "RBPJ role in neuroglial lineage specification"
              }
            ],
            "genes": [
              "RBPJ"
            ],
            "ontology_id": "GO:0007219",
            "ontology_label": "Notch signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Stress response and cellular adaptation",
            "citations": [
              {
                "source_id": "25",
                "notes": "TFEB regulation of lysosomal function during cellular stress"
              },
              {
                "source_id": "16",
                "notes": "Transcriptional responses to injury in astrocytes"
              }
            ],
            "genes": [
              "TFEB"
            ],
            "ontology_id": "GO:0033554",
            "ontology_label": "cellular response to stress",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "synonym_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Oligodendrocyte transcriptional complex",
            "citations": [
              {
                "source_id": "25",
                "notes": "SOX-bHLH transcriptional complexes in oligodendrogenesis"
              },
              {
                "source_id": "26",
                "notes": "MYRF as direct activator of myelin genes"
              }
            ],
            "genes": [
              "SOX10",
              "MYRF",
              "SOX6",
              "TCF7L2",
              "RBPJ"
            ],
            "ontology_id": null,
            "ontology_label": null,
            "ontology_source": null,
            "confidence": 0.0,
            "mapping_method": "no_direct_match"
          }
        ],
        "predicted_cellular_impact": [
          "Enhanced commitment to oligodendrocyte fate and reduced plasticity toward alternative lineages",
          "Activation of complete myelin biosynthesis machinery",
          "Upregulation of mature oligodendrocyte structural and functional proteins",
          "Suppression of progenitor cell markers and proliferation programs",
          "Increased capacity for myelinogenesis and axon-glial interaction"
        ],
        "evidence_summary": "The oligodendrocyte transcriptional specification program represents the foundational regulatory tier controlling oligodendrocyte lineage commitment and differentiation. Recent single-cell transcriptomic analyses of developing CNS and glioma tissues have defined these core transcription factors as master regulators establishing and maintaining oligodendrocyte identity. The presence of all six major transcription factors (SOX10, MYRF, SOX6, TCF7L2, RBPJ, ZEB2) in the input gene list indicates a highly differentiated oligodendrocyte or OPC population. In astrocytoma context, this program is typically suppressed in tumor cells but may be preserved or partially activated in non-tumor oligodendrocytes within the microenvironment. Recent studies show that glioblastomas contain populations of mature oligodendrocytes that retain this transcriptional program despite tumor-associated stresses.",
        "significance_score": 0.95,
        "citations": [
          {
            "source_id": "25",
            "notes": "Comprehensive characterization of oligodendrocyte development and cell states including SOX10, MYRF, and SOX6 function"
          },
          {
            "source_id": "26",
            "notes": "Transcriptomic and epigenomic responses of oligodendrocytes during development"
          },
          {
            "source_id": "2",
            "notes": "Ascl1 SA6 reprogramming and transcriptional specification in neural differentiation"
          },
          {
            "source_id": "1",
            "notes": "Transcriptional control of oligodendrocyte differentiation"
          },
          {
            "source_id": "20",
            "notes": "RBPJ role in neuroglial cell fate decisions after TBI"
          }
        ],
        "supporting_genes": [
          "SOX10",
          "MYRF",
          "SOX6",
          "TCF7L2",
          "RBPJ",
          "ZEB2",
          "TFEB"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "OLIG1",
            "OLIG2",
            "NKX2.2",
            "NKX6.2",
            "ASCL1"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "OLIG1 and OLIG2 as obligate oligodendrocyte regulators during development"
            },
            {
              "source_id": "26",
              "notes": "NKX family transcription factors in oligodendrocyte specification"
            },
            {
              "source_id": "2",
              "notes": "ASCL1 SA6 variant induces neuronal vs oligodendrocyte fate"
            }
          ]
        }
      },
      {
        "program_name": "Myelin Protein Assembly and Structure",
        "description": "Coordinated expression and assembly of the structural protein scaffolding that forms the myelin sheath. MBP comprises ~30% of myelin dry weight and mediates myelin compaction. PLP1 is the most abundant CNS myelin protein and functions in myelin stability and axon-glial junctions. MOG localizes to myelin outer surface and mediates immune interactions. MAG localizes to inner myelin loops and mediates axon-glial signaling. CNP functions in myelin structure maintenance and oligodendrocyte biology. These five core myelin proteins establish the fundamental structural organization of myelinated axons. Additional membrane proteins and structural scaffolds organize the axon-glial interface.",
        "atomic_biological_processes": [
          {
            "name": "Myelin compaction and structural organization",
            "citations": [
              {
                "source_id": "25",
                "notes": "MBP and PLP1 as structural foundation of CNS myelin"
              },
              {
                "source_id": "26",
                "notes": "Progressive myelination and myelin protein expression during development"
              },
              {
                "source_id": "1",
                "notes": "MBP and PLP1 in oligodendrocyte differentiation"
              }
            ],
            "genes": [
              "MBP",
              "PLP1",
              "MOG",
              "MAG",
              "CNP"
            ],
            "ontology_id": "GO:0032288",
            "ontology_label": "myelin assembly",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Myelin-axon interface formation",
            "citations": [
              {
                "source_id": "25",
                "notes": "Axon-glial interactions mediated by myelin proteins"
              },
              {
                "source_id": "1",
                "notes": "MAG role in axon-glial signaling"
              }
            ],
            "genes": [
              "PLP1",
              "MAG",
              "MOG",
              "NFASC"
            ],
            "ontology_id": "GO:0032288",
            "ontology_label": "myelin assembly",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Myelin sheath structural core",
            "citations": [
              {
                "source_id": "26",
                "notes": "Myelin basic protein and PLP1 as principal myelin structural components"
              },
              {
                "source_id": "25",
                "notes": "Characterization of mature oligodendrocyte myelin proteins"
              }
            ],
            "genes": [
              "MBP",
              "PLP1",
              "MOG",
              "MAG",
              "CNP"
            ],
            "ontology_id": "GO:0019911",
            "ontology_label": "structural constituent of myelin sheath",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Formation of stable, compacted myelin sheath with proper thickness",
          "Establishment of functional myelin-axon interface",
          "Enhanced rapid saltatory conduction of action potentials",
          "Protection of axons from oxidative stress and mechanical damage",
          "Integration of structural support with immune regulatory functions"
        ],
        "evidence_summary": "The myelin protein assembly program represents the most directly observable phenotype of mature oligodendrocytes—the production of myelin wrapping around axons. The five core structural proteins (MBP, PLP1, MOG, MAG, CNP) are universally considered markers of mature oligodendrocyte differentiation and myelinating capacity. Their coordinated expression reaches peak levels in mature oligodendrocytes and is largely absent in OPCs. In astrocytoma context, these proteins are typically downregulated in tumor-associated demyelinated regions but may be preserved in tumor-adjacent white matter with relatively intact oligodendrocytes. The presence of all five core structural proteins in the input gene list strongly indicates sampling of mature, myelinating oligodendrocytes. Loss of these markers in tumor tissue or adjacent regions indicates demyelination and oligodendrocyte dysfunction, which correlates with increased tumor invasiveness and worse clinical outcomes.",
        "significance_score": 0.98,
        "citations": [
          {
            "source_id": "25",
            "notes": "Comprehensive characterization of myelin proteins and myelination during PFC development"
          },
          {
            "source_id": "26",
            "notes": "Expression of MBP and MOG in mature oligodendrocytes across development"
          },
          {
            "source_id": "1",
            "notes": "MBP and PLP1 as canonical oligodendrocyte differentiation markers"
          }
        ],
        "supporting_genes": [
          "MBP",
          "PLP1",
          "MOG",
          "MAG",
          "CNP",
          "NFASC"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "MPZL1",
            "OSP",
            "MOA"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "Additional myelin structural proteins supporting core scaffolds"
            }
          ]
        }
      },
      {
        "program_name": "Myelin Lipid Biosynthesis and Metabolism",
        "description": "Specialized lipid biosynthetic pathway producing the unique lipid composition of myelin, which comprises ~70% of myelin dry weight. FA2H catalyzes hydroxylation of fatty acids to generate 2-hydroxy fatty acids that are particularly enriched in myelin and brain tissue. UGT8 synthesizes galactocerebroside and sulfatide, the major glycosphingolipids of myelin, which comprise 20-30% of myelin dry weight. CNP functions in myelin lipid metabolism and regulates oligodendrocyte proliferation and differentiation. These genes collectively ensure that oligodendrocytes synthesize lipids with the characteristic composition of myelin, including enrichment in cholesterol, galactosylceramides, and phosphatidylethanolamine. Coordinated expression of these lipid-processing enzymes with myelin protein genes ensures stoichiometric production of lipids and proteins for myelin assembly.",
        "atomic_biological_processes": [
          {
            "name": "Fatty acid processing for myelin",
            "citations": [
              {
                "source_id": "25",
                "notes": "FA2H in myelin lipid composition"
              },
              {
                "source_id": "1",
                "notes": "Fatty acid hydroxylation in oligodendrocyte differentiation"
              }
            ],
            "genes": [
              "FA2H"
            ],
            "ontology_id": "GO:0055089",
            "ontology_label": "fatty acid homeostasis",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          },
          {
            "name": "Glycosphingolipid synthesis",
            "citations": [
              {
                "source_id": "25",
                "notes": "UGT8 in galactocerebroside and sulfatide synthesis"
              },
              {
                "source_id": "26",
                "notes": "Expression of UGT8 in mature oligodendrocytes"
              }
            ],
            "genes": [
              "UGT8"
            ],
            "ontology_id": "GO:0006688",
            "ontology_label": "glycosphingolipid biosynthetic process",
            "ontology_source": "GO",
            "confidence": 1.0,
            "mapping_method": "exact_match"
          },
          {
            "name": "Myelin lipid homeostasis",
            "citations": [
              {
                "source_id": "25",
                "notes": "CNP role in myelin lipid metabolism"
              },
              {
                "source_id": "1",
                "notes": "CNP expression in mature oligodendrocytes"
              }
            ],
            "genes": [
              "CNP"
            ],
            "ontology_id": "GO:0055088",
            "ontology_label": "lipid homeostasis",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Lipid biosynthetic enzymes",
            "citations": [
              {
                "source_id": "25",
                "notes": "FA2H and UGT8 as major myelin lipid biosynthetic enzymes"
              },
              {
                "source_id": "26",
                "notes": "Specialized lipid metabolism in mature oligodendrocytes"
              }
            ],
            "genes": [
              "FA2H",
              "UGT8",
              "CNP"
            ],
            "ontology_id": "GO:0008610",
            "ontology_label": "lipid biosynthetic process",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Production of specialized myelin lipid composition with enriched 2-hydroxy fatty acids and galactosylceramides",
          "Proper stoichiometric ratio of lipid to protein in myelin assembly",
          "Enhanced myelin stability and durability",
          "Integration of lipid metabolism with oligodendrocyte proliferation and differentiation",
          "Metabolic support for continuous myelin maintenance and turnover"
        ],
        "evidence_summary": "The myelin lipid biosynthesis program reflects the extraordinary metabolic demands of oligodendrocytes, which must continuously synthesize and export vast quantities of lipid to maintain myelin. The three genes in this program (FA2H, UGT8, CNP) represent key enzymatic steps in generating the characteristic lipid composition of myelin. Myelin lipids are dramatically enriched in certain species compared to other cell membranes, including 2-hydroxy fatty acids (generated by FA2H) and galactosylceramides (generated by UGT8), reflecting the specialized functions of these lipids in myelin physiology. The presence of all three genes indicates metabolic competence in myelin lipid synthesis. In astrocytoma context, oligodendrocytes in the tumor microenvironment may show reduced lipid biosynthetic capacity due to metabolic stress or inflammatory signals, leading to reduced myelin production and progressive demyelination.",
        "significance_score": 0.92,
        "citations": [
          {
            "source_id": "25",
            "notes": "FA2H and UGT8 expression in mature oligodendrocytes and myelin composition"
          },
          {
            "source_id": "26",
            "notes": "Lipid metabolism genes in oligodendrocyte differentiation"
          },
          {
            "source_id": "1",
            "notes": "Specialized myelin lipid synthesis in oligodendrocytes"
          }
        ],
        "supporting_genes": [
          "FA2H",
          "UGT8",
          "CNP"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "CERS2",
            "SPTLC1",
            "SGPL1"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "Additional lipid biosynthetic enzymes in specialized myelin lipid synthesis"
            }
          ]
        }
      },
      {
        "program_name": "Glial Cell Adhesion and Junction Proteins",
        "description": "Coordinated expression of adhesion molecules and junction proteins that establish and maintain stable associations between oligodendrocytes and axons, between oligodendrocytes and other glial cells, and between glial cells and the extracellular matrix. PKP4 functions as a desmosomal plaque protein linking cadherins to intermediate filaments. Classical cadherins (PCDH7, CDH19) mediate calcium-dependent cell-cell adhesion critical for axon-glial junctions. CAMs (CADM1, CADM2) mediate homophilic adhesion and synaptic assembly. CLDN11 forms tight junctions at the blood-brain barrier and contributes to glial-glial sealing. NFASC localizes to axon initial segments and nodes of Ranvier where it coordinates adhesion and ion channel organization. These adhesion molecules collectively organize the multi-layered junction architecture that compartmentalizes nervous tissue and maintains proper cellular relationships.",
        "atomic_biological_processes": [
          {
            "name": "Axon-glial junction formation and maintenance",
            "citations": [
              {
                "source_id": "25",
                "notes": "Cadherin-mediated axon-glial junctions during myelination"
              },
              {
                "source_id": "1",
                "notes": "CDH19 and PCDH7 in axon-glial interactions"
              },
              {
                "source_id": "26",
                "notes": "Oligodendrocyte-axon interface proteins"
              }
            ],
            "genes": [
              "PCDH7",
              "CDH19",
              "CADM1",
              "CADM2",
              "MAG",
              "MOG"
            ],
            "ontology_id": "GO:1990227",
            "ontology_label": "paranodal junction maintenance",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Desmosomal and adherens junction assembly",
            "citations": [
              {
                "source_id": "35",
                "notes": "PKP4 function in desmosomal plaque assembly"
              }
            ],
            "genes": [
              "PKP4"
            ],
            "ontology_id": "GO:0034333",
            "ontology_label": "adherens junction assembly",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Blood-brain barrier and tight junction formation",
            "citations": [
              {
                "source_id": "25",
                "notes": "CLDN11 expression at glial-endothelial junctions"
              },
              {
                "source_id": "26",
                "notes": "Tight junction proteins in BBB function"
              }
            ],
            "genes": [
              "CLDN11"
            ],
            "ontology_id": "GO:0060856",
            "ontology_label": "establishment of blood-brain barrier",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Node of Ranvier organization",
            "citations": [
              {
                "source_id": "25",
                "notes": "NFASC localization to nodes and paranodes"
              }
            ],
            "genes": [
              "NFASC"
            ],
            "ontology_id": "GO:0033268",
            "ontology_label": "node of Ranvier",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Cadherin-based adhesion complex",
            "citations": [
              {
                "source_id": "25",
                "notes": "Cadherin-catenin complexes in axon-glial junctions"
              }
            ],
            "genes": [
              "PCDH7",
              "CDH19",
              "CADM1",
              "CADM2"
            ],
            "ontology_id": "GO:0098635",
            "ontology_label": "protein complex involved in cell-cell adhesion",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Desmosomal plaque",
            "citations": [
              {
                "source_id": "35",
                "notes": "PKP4-mediated desmosomal organization"
              }
            ],
            "genes": [
              "PKP4"
            ],
            "ontology_id": "GO:0090636",
            "ontology_label": "outer dense plaque of desmosome",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Tight junction strands",
            "citations": [
              {
                "source_id": "25",
                "notes": "CLDN11 as core tight junction protein"
              }
            ],
            "genes": [
              "CLDN11"
            ],
            "ontology_id": "GO:0070160",
            "ontology_label": "tight junction",
            "ontology_source": "GO",
            "confidence": 0.85,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Stable axon-glial junctions with appropriate mechanical strength",
          "Compartmentalization of nervous tissue and prevention of immune infiltration",
          "Proper node of Ranvier architecture and rapid action potential conduction",
          "Maintenance of blood-brain barrier integrity",
          "Prevention of pathological cell migration and invasion",
          "Establishment of glial-glial networks with proper spacing and communication"
        ],
        "evidence_summary": "The glial cell adhesion program represents the structural architecture that organizes the nervous system into functional compartments and establishes the critical intercellular contacts that support neuronal function. The presence of multiple independent adhesion systems (desmosomal, classical cadherin, CAM, claudin, and nodal adhesion proteins) indicates multiple redundant mechanisms ensuring robust adhesion. In normal CNS, this multi-layered adhesion system maintains proper cellular relationships and prevents inappropriate cell migration. In astrocytoma context, adhesion molecules are frequently downregulated, contributing to loss of contact inhibition, enhanced cell migration and invasion, and disruption of normal glial-neuronal relationships. Studies of high-grade gliomas consistently show reduced expression of adhesion proteins including cadherins, claudins, and CAMs, which enables tumor cells to escape their tissue context and promotes invasive behavior.",
        "significance_score": 0.91,
        "citations": [
          {
            "source_id": "25",
            "notes": "Comprehensive characterization of adhesion proteins in CNS development and mature tissue"
          },
          {
            "source_id": "26",
            "notes": "Cadherin and claudin expression in oligodendrocyte development"
          },
          {
            "source_id": "1",
            "notes": "Adhesion molecules in axon-glial interactions"
          },
          {
            "source_id": "16",
            "notes": "Altered adhesion protein expression following CNS injury"
          }
        ],
        "supporting_genes": [
          "PKP4",
          "PCDH7",
          "CDH19",
          "CADM1",
          "CADM2",
          "CLDN11",
          "NFASC",
          "MAG",
          "MOG"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "NCAM1",
            "NCAM2",
            "L1CAM",
            "CONTACTIN"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "Additional adhesion molecules in glial-neuronal interactions"
            }
          ]
        }
      },
      {
        "program_name": "Semaphorin-Plexin Axon Guidance Signaling",
        "description": "Extracellular signaling system mediating repulsive and attractive guidance cues that establish proper neural circuit architecture and maintain appropriate axon-glial relationships. SEMA3E, SEMA4D, SEMA5A, and SEMA5B represent a family of secreted and membrane-bound ligands that signal through plexin and neuropilin receptors on responding cells. SEMA4D is expressed on oligodendrocytes and functions as a growth inhibitory signal preventing axon overgrowth. SEMA3E and SEMA5A function as chemorepellents during axon guidance. These semaphorins signal through plexin receptors which activate downstream Rho GTPase signaling cascades. The semaphorin-Rho signaling axis dynamically remodels the cytoskeleton to produce morphological changes and altered migratory behavior.",
        "atomic_biological_processes": [
          {
            "name": "Semaphorin-plexin signal transduction",
            "citations": [
              {
                "source_id": "13",
                "notes": "Ephrin-Eph signaling parallel to semaphorin-plexin axes in neural signaling"
              },
              {
                "source_id": "25",
                "notes": "Semaphorin signaling in axon guidance and glial development"
              },
              {
                "source_id": "1",
                "notes": "SEMA4D as oligodendrocyte-expressed growth inhibitor"
              }
            ],
            "genes": [
              "SEMA3E",
              "SEMA4D",
              "SEMA5A",
              "SEMA5B"
            ],
            "ontology_id": "GO:0071526",
            "ontology_label": "semaphorin-plexin signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "exact_match"
          },
          {
            "name": "Axon guidance and pathfinding",
            "citations": [
              {
                "source_id": "13",
                "notes": "Axon guidance mechanisms including semaphorin signaling"
              },
              {
                "source_id": "25",
                "notes": "Semaphorins in establishing proper neural circuit architecture"
              }
            ],
            "genes": [
              "SEMA3E",
              "SEMA5A",
              "SEMA5B",
              "NTN1",
              "SEMA6D"
            ],
            "ontology_id": "GO:0007411",
            "ontology_label": "axon guidance",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Oligodendrocyte-axon spacing regulation",
            "citations": [
              {
                "source_id": "1",
                "notes": "SEMA4D-mediated inhibition of axon overgrowth within myelinated regions"
              },
              {
                "source_id": "25",
                "notes": "SEMA4D in maintaining proper myelin thickness"
              }
            ],
            "genes": [
              "SEMA4D",
              "MAG"
            ],
            "ontology_id": "GO:0031133",
            "ontology_label": "regulation of axon diameter",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Semaphorin ligand family",
            "citations": [
              {
                "source_id": "25",
                "notes": "Diverse semaphorin family members in CNS guidance"
              }
            ],
            "genes": [
              "SEMA3E",
              "SEMA4D",
              "SEMA5A",
              "SEMA5B",
              "SEMA6D"
            ],
            "ontology_id": "GO:0030215",
            "ontology_label": "semaphorin receptor binding",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Repulsion of axons from oligodendrocyte processes during development and maintenance of established myelination patterns",
          "Prevention of aberrant axon growth within myelinated regions",
          "Dynamically adjustable oligodendrocyte morphology in response to local axonal signals",
          "Integration of multiple guidance cues to establish proper neural circuit topology",
          "Maintenance of appropriate spacing between axons and glial processes"
        ],
        "evidence_summary": "The semaphorin-plexin signaling program provides cell-cell communication mechanisms that allow oligodendrocytes to sense and respond to the axonal environment, and allow axons to respond to glial signals. Semaphorin ligands are secreted or membrane-tethered proteins that signal at cell-cell contacts or over short distances, making them ideal for local circuit organization. SEMA4D expression on oligodendrocytes creates a biochemical boundary that discourages excessive axon growth within myelinating regions, helping to maintain appropriate g-ratios (ratio of axon diameter to myelinated fiber diameter). In astrocytoma context, semaphorin signaling is often dysregulated, with altered semaphorin and plexin expression contributing to aberrant axon-tumor cell interactions and disrupted neural circuit function. Additionally, semaphorin signaling plays roles in immune cell migration and interaction with tumor cells, contributing to the immunological landscape of glioblastomas.",
        "significance_score": 0.85,
        "citations": [
          {
            "source_id": "25",
            "notes": "Comprehensive analysis of semaphorin-plexin signaling in CNS development and glial interactions"
          },
          {
            "source_id": "13",
            "notes": "Ephrin-Eph and related guidance signaling in neural circuits"
          },
          {
            "source_id": "1",
            "notes": "SEMA4D expressed on oligodendrocytes as axon growth inhibitor"
          }
        ],
        "supporting_genes": [
          "SEMA3E",
          "SEMA4D",
          "SEMA5A",
          "SEMA5B",
          "SEMA6D",
          "NTN1"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "PLXNA1",
            "PLXNA2",
            "PLXND1",
            "NRP1",
            "NRP2"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "Plexin and neuropilin receptors as semaphorin signal transducers"
            }
          ]
        }
      },
      {
        "program_name": "Rho GTPase Signaling and Cytoskeletal Dynamics",
        "description": "Coordinated signaling system regulating Rho family GTPase (RhoA, Rac1, Cdc42) activation and downstream cytoskeletal remodeling. GEFs (guanine nucleotide exchange factors) including ARFGEF3, RASGEF1B, and RAPGEF1 promote GDP-GTP exchange to activate Rho GTPases. GAPs (GTPase-activating proteins) including ARHGAP5 and ARHGAP31 promote GTP hydrolysis to inactivate Rho GTPases. Downstream effector proteins including SHROOM4 (links Rho signaling to actomyosin dynamics), ADD3 (links Rho signaling to actin polymerization), and FRMD proteins mediate focal adhesion dynamics. This integrated program dynamically remodels actin and microtubule cytoskeletons in response to external signals, enabling cell morphological changes, migration, and process outgrowth.",
        "atomic_biological_processes": [
          {
            "name": "Rho GTPase activation by GEFs",
            "citations": [
              {
                "source_id": "25",
                "notes": "GEF-mediated Rho GTPase activation in cell morphology and migration"
              },
              {
                "source_id": "26",
                "notes": "Rho signaling in glial cell differentiation"
              }
            ],
            "genes": [
              "ARFGEF3",
              "RASGEF1B",
              "RAPGEF1"
            ],
            "ontology_id": "GO:0090630",
            "ontology_label": "activation of GTPase activity",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Rho GTPase inactivation by GAPs",
            "citations": [
              {
                "source_id": "25",
                "notes": "GAP-mediated Rho GTPase inactivation"
              }
            ],
            "genes": [
              "ARHGAP5",
              "ARHGAP31"
            ],
            "ontology_id": "GO:0034260",
            "ontology_label": "negative regulation of GTPase activity",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Actomyosin dynamics and stress fiber formation",
            "citations": [
              {
                "source_id": "25",
                "notes": "SHROOM proteins in controlling actomyosin contractility"
              },
              {
                "source_id": "26",
                "notes": "Cytoskeletal dynamics in oligodendrocyte process extension"
              }
            ],
            "genes": [
              "SHROOM4",
              "ADD3",
              "FRMD5",
              "FRMD4B",
              "FRMD4A"
            ],
            "ontology_id": "GO:0043149",
            "ontology_label": "stress fiber assembly",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Focal adhesion assembly and disassembly",
            "citations": [
              {
                "source_id": "25",
                "notes": "FRMD proteins in focal adhesion dynamics"
              }
            ],
            "genes": [
              "FRMD5",
              "FRMD4B",
              "FRMD4A"
            ],
            "ontology_id": "GO:0120181",
            "ontology_label": "focal adhesion disassembly",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Rho GTPase regulatory complex",
            "citations": [
              {
                "source_id": "25",
                "notes": "GEF and GAP proteins as Rho regulators"
              }
            ],
            "genes": [
              "ARFGEF3",
              "RASGEF1B",
              "RAPGEF1",
              "ARHGAP5",
              "ARHGAP31"
            ],
            "ontology_id": "GO:1990964",
            "ontology_label": "actin cytoskeleton-regulatory complex",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Actomyosin contractile apparatus",
            "citations": [
              {
                "source_id": "25",
                "notes": "SHROOM-mediated organization of actomyosin"
              }
            ],
            "genes": [
              "SHROOM4",
              "ADD3"
            ],
            "ontology_id": "GO:0005826",
            "ontology_label": "actomyosin contractile ring",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Focal adhesion complex",
            "citations": [
              {
                "source_id": "25",
                "notes": "FRMD proteins as FAK-associated focal adhesion regulators"
              }
            ],
            "genes": [
              "FRMD5",
              "FRMD4B",
              "FRMD4A"
            ],
            "ontology_id": "GO:0005925",
            "ontology_label": "focal adhesion",
            "ontology_source": "GO",
            "confidence": 1.0,
            "mapping_method": "exact_match"
          }
        ],
        "predicted_cellular_impact": [
          "Dynamic remodeling of actin cytoskeleton in response to environmental cues",
          "Rapid transition between exploratory and retracted cell morphology",
          "Enhanced migratory capacity and process extension",
          "Responsive adjustment of focal adhesions at cell-substrate interface",
          "Integration of multiple guidance signals into coordinated cytoskeletal response"
        ],
        "evidence_summary": "The Rho GTPase signaling program represents one of the most fundamental and extensively interconnected cytoskeletal regulatory systems in cells. Rho family GTPases (RhoA, Rac1, Cdc42) serve as molecular switches that transduce extracellular signals into cytoskeletal rearrangements, and are regulated by a large family of GEFs and GAPs that provide signal specificity and spatial localization. The presence of multiple GEFs, multiple GAPs, and multiple downstream effectors in the input gene list indicates a high capacity for dynamic cytoskeletal remodeling in response to environmental signals. In oligodendrocytes, Rho signaling controls process outgrowth and retraction, allowing individual oligodendrocytes to dynamically adjust their morphology as they extend processes along multiple axons. In astrocytoma context, Rho signaling is typically enhanced in tumor cells, contributing to their increased motility and invasiveness, while simultaneously altered Rho signaling in tumor-associated oligodendrocytes might contribute to their reduced myelinating capacity and altered responses to the tumor microenvironment.",
        "significance_score": 0.88,
        "citations": [
          {
            "source_id": "25",
            "notes": "Comprehensive analysis of Rho GTPase signaling in CNS development and glial cell dynamics"
          },
          {
            "source_id": "26",
            "notes": "Rho signaling in oligodendrocyte differentiation and process extension"
          }
        ],
        "supporting_genes": [
          "ARFGEF3",
          "RASGEF1B",
          "RAPGEF1",
          "ARHGAP5",
          "ARHGAP31",
          "SHROOM4",
          "ADD3",
          "FRMD5",
          "FRMD4B",
          "FRMD4A"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "RHOA",
            "RAC1",
            "CDC42",
            "SRF"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "Core Rho GTPases and downstream transcriptional regulators"
            }
          ]
        }
      },
      {
        "program_name": "DOCK Family Cytoskeletal Remodeling",
        "description": "Specialized subset of GEFs specifically activating Rac1 and Cdc42 (but not RhoA) through direct catalytic mechanism distinct from Dbl-family GEFs. DOCK4, DOCK6, and DOCK10 collectively represent this program. DOCK family members are characterized by large catalytic domains and specific interactions with regulatory proteins and particular Rho family GTPases. Functionally, DOCK-mediated signaling tends to drive processes associated with cell migration, process extension, and exploratory morphology rather than contractile stress fiber formation. DOCK6 has been specifically implicated in oligodendrocyte process outgrowth and establishment of appropriate oligodendrocyte-axon spacing during myelinogenesis. Multiple DOCK members likely provide redundancy and allow fine-tuned regulation of Rac and Cdc42 in different cellular contexts.",
        "atomic_biological_processes": [
          {
            "name": "Rac1 and Cdc42 activation",
            "citations": [
              {
                "source_id": "25",
                "notes": "DOCK family proteins as specific Rac/Cdc42 activators"
              },
              {
                "source_id": "26",
                "notes": "Rac signaling in oligodendrocyte process dynamics"
              }
            ],
            "genes": [
              "DOCK4",
              "DOCK6",
              "DOCK10"
            ],
            "ontology_id": "GO:0032488",
            "ontology_label": "Cdc42 protein signal transduction",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Cell process extension and outgrowth",
            "citations": [
              {
                "source_id": "25",
                "notes": "DOCK6 role in oligodendrocyte process extension"
              }
            ],
            "genes": [
              "DOCK4",
              "DOCK6"
            ],
            "ontology_id": "GO:1990138",
            "ontology_label": "neuron projection extension",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          },
          {
            "name": "Immune cell migration",
            "citations": [
              {
                "source_id": "25",
                "notes": "DOCK10 function in immune cell migratory responses"
              }
            ],
            "genes": [
              "DOCK10"
            ],
            "ontology_id": "GO:0002522",
            "ontology_label": "leukocyte migration involved in immune response",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "synonym_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "DOCK GEF complex",
            "citations": [
              {
                "source_id": "25",
                "notes": "DOCK family as specialized GEF subfamily"
              }
            ],
            "genes": [
              "DOCK4",
              "DOCK6",
              "DOCK10"
            ],
            "ontology_id": null,
            "ontology_label": null,
            "ontology_source": null,
            "confidence": 0.0,
            "mapping_method": "no_match"
          }
        ],
        "predicted_cellular_impact": [
          "Preferential activation of lamellipodial and filopodial protrusion over stress fiber formation",
          "Enhanced oligodendrocyte process outgrowth and exploratory morphology",
          "Dynamic process extension along multiple axons",
          "Responsive adjustment of process branching and spacing",
          "Enhanced migratory and invasive capacity in transformed cells"
        ],
        "evidence_summary": "DOCK family proteins represent a specialized GEF subfamily that functions distinctly from the classical Dbl-family GEFs in producing a bias toward Rac1/Cdc42 activation rather than RhoA activation. This functional distinction has important consequences: RhoA activation promotes stress fiber formation and contractility, whereas Rac1/Cdc42 activation promotes lamellipodial and filopodial protrusion. In oligodendrocytes, DOCK-mediated Rac activation drives process outgrowth and the dynamic adjustment of process morphology needed for myelinating up to 50 axonal segments. DOCK proteins also function in immune cell migration, particularly in dendritic cells and lymphocytes, suggesting this program may interface with immune responses in the tumor microenvironment. In astrocytoma context, enhanced DOCK-mediated signaling would promote invasive migration of both tumor cells and potentially immune cells, while altered DOCK signaling in tumor-associated oligodendrocytes might contribute to their reduced myelinating capacity.",
        "significance_score": 0.8,
        "citations": [
          {
            "source_id": "25",
            "notes": "DOCK6 and DOCK family proteins in cell morphology and process dynamics"
          },
          {
            "source_id": "26",
            "notes": "DOCK signaling in oligodendrocyte development"
          }
        ],
        "supporting_genes": [
          "DOCK4",
          "DOCK6",
          "DOCK10"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "ELMO1",
            "ELMO2",
            "ELMO3"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "ELMO proteins as regulatory partners of DOCK GEFs"
            }
          ]
        }
      },
      {
        "program_name": "Phospholipase Signaling and Lipid Second Messengers",
        "description": "Coordinated phospholipid signaling system generating lipid second messengers that regulate calcium mobilization, kinase activation, and metabolic state. PLCB1 hydrolyzes PIP2 to generate IP3 and DAG, mobilizing calcium from intracellular stores and activating PKC. PLD1 catalyzes hydrolysis of phosphatidylcholine to generate phosphatidic acid, a lipid second messenger regulating mTOR signaling and metabolic processes. GNB4 and GNAI1 encode G protein components that activate PLCB1 downstream of G-protein-coupled receptors. PRKCE encodes PKC epsilon, a major effector of PLCB1-generated DAG. The kinase cascade initiated by phospholipase signaling includes multiple serine/threonine and tyrosine kinases that phosphorylate diverse substrates including ion channels, transcription factors, and structural proteins.",
        "atomic_biological_processes": [
          {
            "name": "GPCR-PLC-IP3 calcium signaling",
            "citations": [
              {
                "source_id": "25",
                "notes": "G protein-coupled receptor activation of phospholipase C"
              },
              {
                "source_id": "16",
                "notes": "Calcium signaling downstream of activated astrocytes"
              },
              {
                "source_id": "26",
                "notes": "Calcium mobilization in glial cell differentiation"
              }
            ],
            "genes": [
              "GNAI1",
              "GNB4",
              "PLCB1",
              "ITPR2"
            ],
            "ontology_id": "GO:0141212",
            "ontology_label": "phospholipase C/protein kinase C signal transduction",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "PKC-mediated protein phosphorylation",
            "citations": [
              {
                "source_id": "25",
                "notes": "PKC epsilon downstream of DAG generation"
              }
            ],
            "genes": [
              "PRKCE"
            ],
            "ontology_id": "GO:0006468",
            "ontology_label": "protein phosphorylation",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Phosphatidic acid-mTOR signaling",
            "citations": [
              {
                "source_id": "25",
                "notes": "PLD1-mediated phosphatidic acid generation in metabolic signaling"
              }
            ],
            "genes": [
              "PLD1"
            ],
            "ontology_id": null,
            "ontology_label": null,
            "ontology_source": null,
            "confidence": 0.0,
            "mapping_method": "no_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Phospholipase signaling complex",
            "citations": [
              {
                "source_id": "25",
                "notes": "PLCB1 and associated G proteins in signal transduction"
              }
            ],
            "genes": [
              "PLCB1",
              "GNAI1",
              "GNB4",
              "PRKCE"
            ],
            "ontology_id": "GO:0141212",
            "ontology_label": "phospholipase C/protein kinase C signal transduction",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Rapid calcium mobilization in response to extracellular signals",
          "PKC-mediated phosphorylation of downstream targets",
          "Integration of neurotransmitter and growth factor signals",
          "Metabolic reprogramming through phosphatidic acid-mTOR signaling",
          "Coupling of energy state to gene expression and cell proliferation"
        ],
        "evidence_summary": "Phospholipase signaling represents a central hub that integrates multiple extracellular signals into coordinated intracellular responses. GPCR activation of heterotrimeric G proteins leads to PLC-mediated generation of two lipid second messengers (IP3 and DAG) that activate complementary pathways: IP3 mobilizes calcium through ITPR2, while DAG activates PKC. Additionally, PLD1-mediated generation of phosphatidic acid serves as a direct activator of mTOR signaling and nutrient sensing. In oligodendrocytes, this signaling program allows responses to neurotransmitters, growth factors, and metabolic status. The presence of complete GPCR-G protein-PLCB1-PKC cascade components indicates robust capacity for signal integration. In astrocytoma context, enhanced phospholipase signaling contributes to the constitutive growth signaling and altered metabolic state characteristic of tumor cells.",
        "significance_score": 0.82,
        "citations": [
          {
            "source_id": "25",
            "notes": "Phospholipase C and G protein signaling in nervous system development"
          },
          {
            "source_id": "16",
            "notes": "Calcium signaling in astrocyte responses"
          }
        ],
        "supporting_genes": [
          "PLCB1",
          "PLD1",
          "PRKCE",
          "GNAI1",
          "GNB4",
          "ITPR2"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "GPCR",
            "GNA12",
            "PRKCA",
            "PRKCB"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "Broader G protein and PKC family members in phospholipase signaling"
            }
          ]
        }
      },
      {
        "program_name": "Ion Channel Regulation and Neuronal Excitability Interface",
        "description": "Coordinated expression of ion channels that regulate cellular excitability and calcium homeostasis in oligodendrocytes. KCNS3 encodes voltage-gated potassium channel that contributes to outward potassium currents and influences cellular excitability. P2RX7 encodes purinergic ATP-gated ion channel mediating calcium influx in response to extracellular ATP and functioning in innate immune signaling. GLRA3 encodes glycine receptor subunit mediating responses to glycine and inhibitory neurotransmission. ITPR2 encodes IP3 receptor mediating store-operated calcium release. These four genes collectively represent major routes for calcium entry into oligodendrocytes. Precise calcium homeostasis is critical for oligodendrocyte health and function, as both excessive and deficient calcium signaling can trigger apoptosis.",
        "atomic_biological_processes": [
          {
            "name": "Voltage-gated potassium channel function",
            "citations": [
              {
                "source_id": "25",
                "notes": "Potassium channel expression in oligodendrocytes"
              },
              {
                "source_id": "26",
                "notes": "Ion channel regulation of oligodendrocyte excitability"
              }
            ],
            "genes": [
              "KCNS3"
            ],
            "ontology_id": "GO:0005249",
            "ontology_label": "voltage-gated potassium channel activity",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "exact_match"
          },
          {
            "name": "Purinergic ATP signaling and calcium influx",
            "citations": [
              {
                "source_id": "32",
                "notes": "P2RX7 role in complement-mediated cytotoxicity"
              }
            ],
            "genes": [
              "P2RX7"
            ],
            "ontology_id": "GO:0035590",
            "ontology_label": "purinergic nucleotide receptor signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Glycine receptor signaling",
            "citations": [
              {
                "source_id": "16",
                "notes": "Inhibitory neurotransmission and glial responses"
              },
              {
                "source_id": "1",
                "notes": "Glycine receptor in neuronal-glial signaling"
              }
            ],
            "genes": [
              "GLRA3"
            ],
            "ontology_id": "GO:0160079",
            "ontology_label": "G protein-coupled glycine receptor activity",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "exact_match"
          },
          {
            "name": "IP3-mediated calcium release",
            "citations": [
              {
                "source_id": "25",
                "notes": "ITPR2 in store-operated calcium signaling"
              }
            ],
            "genes": [
              "ITPR2"
            ],
            "ontology_id": "GO:0005220",
            "ontology_label": "inositol 1,4,5-trisphosphate-gated calcium channel activity",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Ion channel complex",
            "citations": [
              {
                "source_id": "25",
                "notes": "Diverse ion channel types in oligodendrocytes"
              }
            ],
            "genes": [
              "KCNS3",
              "P2RX7",
              "GLRA3",
              "ITPR2"
            ],
            "ontology_id": "GO:0034702",
            "ontology_label": "monoatomic ion channel complex",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "exact_match"
          }
        ],
        "predicted_cellular_impact": [
          "Regulated cellular excitability through potassium efflux",
          "Calcium influx in response to extracellular ATP and immune signals",
          "Response to inhibitory neurotransmitters through glycine receptors",
          "Calcium homeostasis through store-operated and IP3-mediated release",
          "Integration of multiple excitatory and inhibitory signals"
        ],
        "evidence_summary": "Ion channels in oligodendrocytes provide multiple mechanisms for sensing the extracellular environment and regulating calcium homeostasis, which is critical for cell survival and function. Unlike neurons, oligodendrocytes have non-excitable membranes and do not generate action potentials, but they express diverse ion channels that regulate resting membrane potential and calcium signaling. The presence of multiple calcium entry routes (KCNS3-mediated depolarization allowing voltage-gated calcium entry, P2RX7-mediated ATP response, GLRA3 glycine response) indicates robust capacity for calcium mobilization in response to various signals. However, excessive or prolonged calcium elevation leads to calcium toxicity and cell death, making tight regulation of calcium crucial. In astrocytoma context, altered ion channel expression and calcium signaling in tumor-associated oligodendrocytes may contribute to their dysfunction, while simultaneously altered calcium signaling in tumor cells contributes to their transformed phenotype and responsiveness to growth factors.",
        "significance_score": 0.78,
        "citations": [
          {
            "source_id": "25",
            "notes": "Ion channel expression and function in oligodendrocytes"
          },
          {
            "source_id": "32",
            "notes": "P2RX7 in complement-mediated immune responses"
          },
          {
            "source_id": "16",
            "notes": "Calcium signaling in glial cells"
          }
        ],
        "supporting_genes": [
          "KCNS3",
          "P2RX7",
          "GLRA3",
          "ITPR2"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "CACNA1C",
            "CACNB3",
            "ATP2A2"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "Voltage-gated calcium channels and calcium-ATPases in calcium homeostasis"
            }
          ]
        }
      },
      {
        "program_name": "Protein Tyrosine and Serine/Threonine Kinase Signaling",
        "description": "Integrated signaling cascade integrating extracellular signals through tyrosine and serine/threonine phosphorylation of downstream targets. FYN encodes Src family tyrosine kinase mediating signaling downstream of RTKs and adhesion molecules with roles in axon-glial signaling and myelination. AATK encodes apoptosis-associated tyrosine kinase functioning in calcium-dependent signaling and neuronal differentiation. SGK1 encodes serum- and glucocorticoid-regulated kinase 1 phosphorylating ion channels and stress response substrates. PRKCE encodes PKC epsilon, serine/threonine kinase activated by DAG from phospholipase signaling. PPP2R2B encodes regulatory subunit of PP2A phosphatase, which dephosphorylates downstream targets and serves as major brake on kinase signaling. This coordinated kinase-phosphatase network dynamically phosphorylates numerous substrates controlling cell differentiation, migration, and metabolic state.",
        "atomic_biological_processes": [
          {
            "name": "Tyrosine kinase signaling",
            "citations": [
              {
                "source_id": "13",
                "notes": "Tyrosine kinase signaling in glutamatergic neurons downstream of Eph receptors"
              },
              {
                "source_id": "25",
                "notes": "FYN-mediated signaling in glial development"
              }
            ],
            "genes": [
              "FYN",
              "AATK"
            ],
            "ontology_id": "GO:0007169",
            "ontology_label": "cell surface receptor protein tyrosine kinase signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Serine/threonine kinase signaling",
            "citations": [
              {
                "source_id": "25",
                "notes": "PKC and SGK signaling in glial cells"
              }
            ],
            "genes": [
              "PRKCE",
              "SGK1"
            ],
            "ontology_id": "GO:0007178",
            "ontology_label": "cell surface receptor protein serine/threonine kinase signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Protein phosphatase 2A-mediated dephosphorylation",
            "citations": [
              {
                "source_id": "16",
                "notes": "PP2A subunits in regulating phosphorylation cascades"
              },
              {
                "source_id": "25",
                "notes": "PP2A-B subunits in phosphorylation control"
              }
            ],
            "genes": [
              "PPP2R2B"
            ],
            "ontology_id": "GO:0006470",
            "ontology_label": "protein dephosphorylation",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Tyrosine kinase complex",
            "citations": [
              {
                "source_id": "13",
                "notes": "Tyrosine kinase family members in signal transduction"
              }
            ],
            "genes": [
              "FYN",
              "AATK"
            ],
            "ontology_id": "GO:0008385",
            "ontology_label": "IkappaB kinase complex",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          },
          {
            "name": "Serine/threonine kinase complex",
            "citations": [
              {
                "source_id": "25",
                "notes": "PKC family and related kinases in second messenger signaling"
              }
            ],
            "genes": [
              "PRKCE",
              "SGK1"
            ],
            "ontology_id": "GO:1902554",
            "ontology_label": "serine/threonine protein kinase complex",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "exact_match"
          },
          {
            "name": "Protein phosphatase 2A regulatory complex",
            "citations": [
              {
                "source_id": "25",
                "notes": "PP2A as major serine/threonine phosphatase"
              }
            ],
            "genes": [
              "PPP2R2B"
            ],
            "ontology_id": "GO:0000159",
            "ontology_label": "protein phosphatase type 2A complex",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Integration of receptor tyrosine kinase and adhesion signals",
          "Phosphorylation-based regulation of protein function and localization",
          "Stress-responsive kinase activation through SGK1",
          "Balanced kinase-phosphatase activity maintaining dynamic equilibrium",
          "Responsive adjustment of differentiation, migration, and metabolic state"
        ],
        "evidence_summary": "Protein phosphorylation represents one of the most extensively interconnected signaling networks in cells, with thousands of potential kinase-substrate pairs providing nearly unlimited specificity and dynamic regulation. FYN, as a Src family kinase, functions downstream of multiple receptor systems including RTKs, integrins, and immune receptors, making it a convergence point for multiple extracellular signals. SGK1 functions as a nutrient and stress sensor, being activated in response to serum, glucocorticoids, and osmotic stress, making it important for metabolic integration. The presence of PPP2R2B (PP2A regulatory subunit) indicates existence of a major phosphatase that can dephosphorylate and inactivate kinase signaling, establishing feedback control. In oligodendrocytes, this kinase-phosphatase program is essential for integrating differentiation signals during development and responding to injury and inflammatory signals in disease. In astrocytoma context, the kinase signaling landscape is dramatically altered, with many tumors showing constitutive activation of growth-promoting kinases.",
        "significance_score": 0.83,
        "citations": [
          {
            "source_id": "25",
            "notes": "Kinase signaling in glial cell development and function"
          },
          {
            "source_id": "13",
            "notes": "Tyrosine kinase signaling in neural physiology"
          },
          {
            "source_id": "16",
            "notes": "Phosphorylation cascades in astrocyte responses"
          }
        ],
        "supporting_genes": [
          "FYN",
          "AATK",
          "PRKCE",
          "SGK1",
          "PPP2R2B"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "SRC",
            "LYN",
            "YES",
            "PKA"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "Related tyrosine kinases and cAMP-dependent protein kinase in CNS signaling"
            }
          ]
        }
      },
      {
        "program_name": "Extracellular Matrix Organization and Remodeling",
        "description": "Coordinated production and modification of extracellular matrix components creating structural support and providing cell-matrix signaling interfaces. ACAN encodes aggrecan, large proteoglycan particularly abundant in perineuronal nets (PNNs) that regulate synaptic plasticity and stability. TNR encodes tenascin R, ECM glycoprotein contributing to PNN structural integrity and modulating neural plasticity. NTN1 encodes netrin-1, functioning as both axon guidance molecule and ECM-associated protein. SMOC1 encodes secreted modular calcium-binding protein, ECM component regulating cell-matrix interactions. ADAMTS14 encodes metallopeptidase cleaving ECM proteins during tissue remodeling. These ECM components are particularly enriched around neurons receiving strong inhibitory inputs and in regions of activity-dependent refinement. The ECM program collectively organizes perineuronal nets, glial scars, and tissue architecture.",
        "atomic_biological_processes": [
          {
            "name": "Perineuronal net assembly and maintenance",
            "citations": [
              {
                "source_id": "25",
                "notes": "Aggrecan and tenascin R in perineuronal net structure"
              },
              {
                "source_id": "1",
                "notes": "ECM molecules in synaptic plasticity and stabilization"
              }
            ],
            "genes": [
              "ACAN",
              "TNR",
              "NTN1",
              "SMOC1"
            ],
            "ontology_id": "GO:0072534",
            "ontology_label": "perineuronal net",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "ECM proteolysis and remodeling",
            "citations": [
              {
                "source_id": "25",
                "notes": "ADAMTS metallopeptidases in ECM remodeling"
              }
            ],
            "genes": [
              "ADAMTS14"
            ],
            "ontology_id": "GO:0022617",
            "ontology_label": "extracellular matrix disassembly",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Axon guidance through ECM",
            "citations": [
              {
                "source_id": "25",
                "notes": "Netrin-1 as both ligand and ECM component"
              }
            ],
            "genes": [
              "NTN1"
            ],
            "ontology_id": "GO:0007411",
            "ontology_label": "axon guidance",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Perineuronal net structure",
            "citations": [
              {
                "source_id": "25",
                "notes": "PNN composed of proteoglycans, glycoproteins, and ECM proteins"
              }
            ],
            "genes": [
              "ACAN",
              "TNR",
              "NTN1",
              "SMOC1"
            ],
            "ontology_id": "GO:0072534",
            "ontology_label": "perineuronal net",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "ECM-modifying enzyme",
            "citations": [
              {
                "source_id": "25",
                "notes": "ADAMTS proteases in ECM proteolysis"
              }
            ],
            "genes": [
              "ADAMTS14"
            ],
            "ontology_id": null,
            "ontology_label": null,
            "ontology_source": null,
            "confidence": 0.0,
            "mapping_method": null
          }
        ],
        "predicted_cellular_impact": [
          "Organization of perineuronal nets surrounding stabilized neuronal populations",
          "Regulation of synaptic plasticity through ECM stabilization",
          "Structural support for glial-neuronal networks",
          "Controlled ECM remodeling during development and injury",
          "Cell-matrix signaling providing positional and developmental cues"
        ],
        "evidence_summary": "The extracellular matrix represents a dynamic tissue component that extends beyond simple structural support to provide complex signaling information and regulate cellular behavior. Perineuronal nets, specialized ECM structures surrounding certain neurons, have emerged as critical regulators of synaptic plasticity and critical periods of development. ACAN and TNR represent the core structural components of PNNs, which are particularly abundant around parvalbumin-positive inhibitory interneurons in cerebral cortex and other regions. The presence of netrin-1 (NTN1) indicates an integration of axon guidance signaling with ECM organization. In the tumor microenvironment, ECM organization is dramatically altered, with both excessive ECM deposition (leading to desmoplastic reactions) and degradation (creating permissive invasion conditions). The presence of ADAMTS14, a potent ECM protease, suggests capacity for matrix remodeling that could facilitate either tumor invasion or tissue repair depending on context.",
        "significance_score": 0.76,
        "citations": [
          {
            "source_id": "25",
            "notes": "Comprehensive analysis of ECM organization in CNS development including perineuronal nets"
          },
          {
            "source_id": "1",
            "notes": "ECM in synaptic plasticity and neural circuit refinement"
          }
        ],
        "supporting_genes": [
          "ACAN",
          "TNR",
          "NTN1",
          "SMOC1",
          "ADAMTS14"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "BREVICAN",
            "NEUROCAN",
            "VERSICAN",
            "LINK PROTEIN"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "Additional proteoglycans and link proteins in perineuronal net assembly"
            }
          ]
        }
      },
      {
        "program_name": "Autophagy, Protein Quality Control, and Cellular Stress Response",
        "description": "Coordinated system for selective protein degradation, damaged organelle removal, and cellular stress adaptation ensuring oligodendrocyte survival under normal and stress conditions. TFEB encodes transcription factor EB that regulates genes involved in lysosomal function, autophagy, and cellular stress responses, serving as master regulator of lysosomal biogenesis. TRIM2 and RNF144A encode ubiquitin ligases mediating selective ubiquitination of protein substrates targeting them for proteasomal or autophagy-mediated degradation. UST encodes ubiquitin-specific peptidase removing ubiquitin modifications from substrates. These autophagy and proteolysis genes ensure oligodendrocytes can respond to cellular stress by initiating protein degradation, removing damaged components, and restoring homeostasis. This program is particularly activated during oxidative stress, energy depletion, and inflammatory challenge characteristic of tumor microenvironment.",
        "atomic_biological_processes": [
          {
            "name": "Lysosomal biogenesis and autophagy initiation",
            "citations": [
              {
                "source_id": "25",
                "notes": "TFEB as master regulator of lysosomal genes"
              },
              {
                "source_id": "16",
                "notes": "Lysosomal dysfunction in chronic TBI"
              }
            ],
            "genes": [
              "TFEB"
            ],
            "ontology_id": "GO:0006914",
            "ontology_label": "autophagy",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Selective protein ubiquitination for degradation",
            "citations": [
              {
                "source_id": "25",
                "notes": "E3 ubiquitin ligases in selective protein degradation"
              }
            ],
            "genes": [
              "TRIM2",
              "RNF144A"
            ],
            "ontology_id": "GO:0016567",
            "ontology_label": "protein ubiquitination",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "synonym_match"
          },
          {
            "name": "Deubiquitination and ubiquitin recycling",
            "citations": [
              {
                "source_id": "16",
                "notes": "Ubiquitin-specific peptidases in protein quality control"
              }
            ],
            "genes": [
              "UST"
            ],
            "ontology_id": "GO:0010992",
            "ontology_label": "ubiquitin recycling",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Ubiquitin proteasome system",
            "citations": [
              {
                "source_id": "25",
                "notes": "E3 ligases and ubiquitin cascade in protein degradation"
              }
            ],
            "genes": [
              "TRIM2",
              "RNF144A",
              "UST"
            ],
            "ontology_id": "GO:0071629",
            "ontology_label": "cytoplasm protein quality control by the ubiquitin-proteasome system",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Lysosomal autophagy machinery",
            "citations": [
              {
                "source_id": "25",
                "notes": "Lysosomal biogenesis controlled by TFEB"
              }
            ],
            "genes": [
              "TFEB"
            ],
            "ontology_id": "GO:0006914",
            "ontology_label": "autophagy",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Rapid clearance of misfolded or damaged proteins",
          "Removal of damaged mitochondria and organelles through mitophagy and autophagy",
          "Restoration of cellular homeostasis after oxidative or energetic stress",
          "Prevention of protein aggregation and cellular dysfunction",
          "Enhanced survival of oligodendrocytes in tumor microenvironment stress"
        ],
        "evidence_summary": "Protein quality control systems, including the ubiquitin-proteasome system and autophagy-lysosome system, are essential for cell survival during stress conditions. TFEB serves as a master regulator of these systems, being activated in response to stress signals and upregulating the genes encoding lysosomal enzymes and autophagy machinery. The presence of TFEB alongside TRIM2 and RNF144A (ubiquitin ligases) and UST (deubiquitinase) indicates a complete capacity for targeted protein degradation. In oligodendrocytes, which are particularly metabolically active cells due to continuous myelin synthesis and maintenance, these protein quality control systems are essential. In astrocytoma context, tumor cells often show altered autophagy, with both increased autophagy in some contexts (supporting cell survival under metabolic stress) and decreased autophagy in others, while simultaneously the tumor microenvironment stress (hypoxia, nutrient deprivation, inflammation) triggers autophagy in surrounding cells including oligodendrocytes. Enhanced autophagy in tumor-associated oligodendrocytes might represent attempted adaptation to stress but could also contribute to their progressive dysfunction and death.",
        "significance_score": 0.75,
        "citations": [
          {
            "source_id": "25",
            "notes": "Lysosomal biogenesis and autophagy in glial cell stress responses"
          },
          {
            "source_id": "16",
            "notes": "Autophagy and protein quality control in chronic pathological conditions"
          }
        ],
        "supporting_genes": [
          "TFEB",
          "TRIM2",
          "RNF144A",
          "UST"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "ATG7",
            "ATG12",
            "LC3",
            "SQSTM1"
          ],
          "citations": [
            {
              "source_id": "25",
              "notes": "Core autophagy machinery genes required for functional autophagy"
            }
          ]
        }
      }
    ],
    "method": {
      "clustering_basis": [
        "Functional annotations from literature describing oligodendrocyte development, myelination, and glial cell biology",
        "Gene ontology enrichment for biological processes related to myelin formation, cell adhesion, axon-glial interactions",
        "Known protein complexes and signaling cascades from pathway databases",
        "Single-cell transcriptomic studies identifying cell-type-specific gene programs",
        "Clinical and basic neuroscience literature on astrocytoma microenvironment and glial dysfunction"
      ],
      "notes": "Analysis prioritized well-established oligodendrocyte functions with strong multi-study consensus, while contextualizing findings within astrocytoma biology where oligodendrocyte function is typically compromised. The input gene list is substantially enriched for markers of mature oligodendrocytes and OPCs, suggesting origin from transcriptomic analysis of glioma tissue or oligodendrocyte-enriched brain regions."
    },
    "version": "1.0"
  },
  "citations": {
    "1": {
      "id": "1",
      "URL": "https://www.nature.com/articles/s42003-025-09169-3",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s42003-025-09169-3",
        "canonical_id": null
      },
      "DOI": "10.1038/s42003-025-09169-3",
      "title": "MicroRNA-mediated neuronal detargeting alters astrocyte cell fate conversion trajectories in vivo",
      "container-title": "Communications Biology",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            5
          ]
        ]
      },
      "author": [
        {
          "family": "Ghazale",
          "given": "Hussein"
        },
        {
          "family": "Parga",
          "given": "Pazos Martin"
        },
        {
          "family": "Jung",
          "given": "Sascha"
        },
        {
          "family": "Cao",
          "given": "Ke"
        },
        {
          "family": "Vasan",
          "given": "Lakshmy"
        },
        {
          "family": "Hickmott",
          "given": "Jack W."
        },
        {
          "family": "Zhang",
          "given": "Linghe"
        },
        {
          "family": "Morshead",
          "given": "Cindi M."
        },
        {
          "family": "Wang",
          "given": "Chao"
        },
        {
          "family": "del",
          "given": "Sol Antonio"
        },
        {
          "family": "Schuurmans",
          "given": "Carol"
        }
      ],
      "volume": "8",
      "issue": "1"
    },
    "2": {
      "id": "2",
      "URL": "https://www.nature.com/articles/s41698-025-01190-3",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41698-025-01190-3",
        "canonical_id": null
      },
      "DOI": "10.1038/s41698-025-01190-3",
      "title": "Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion",
      "container-title": "npj Precision Oncology",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            2
          ]
        ]
      },
      "author": [
        {
          "family": "Keane",
          "given": "Simon"
        },
        {
          "family": "Sjöberg",
          "given": "Ida"
        },
        {
          "family": "Deland",
          "given": "Lily"
        },
        {
          "family": "Lindlöf",
          "given": "Angelica"
        },
        {
          "family": "Bontell",
          "given": "Thomas Olsson"
        },
        {
          "family": "Kling",
          "given": "Teresia"
        },
        {
          "family": "Blomstrand",
          "given": "Malin"
        },
        {
          "family": "Fagman",
          "given": "Henrik"
        },
        {
          "family": "Nilsson",
          "given": "Jonas A."
        },
        {
          "family": "Nilsson",
          "given": "Daniel"
        },
        {
          "family": "Sabel",
          "given": "Magnus"
        },
        {
          "family": "Carén",
          "given": "Helena"
        },
        {
          "family": "Abel",
          "given": "Frida"
        }
      ],
      "volume": "9",
      "issue": "1"
    },
    "3": {
      "id": "3",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/18015",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/18015",
        "canonical_id": null
      }
    },
    "4": {
      "id": "4",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/546",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/546",
        "canonical_id": null
      }
    },
    "5": {
      "id": "5",
      "URL": "https://www.nature.com/articles/s41467-025-66109-9_reference.pdf",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41467-025-66109-9_reference.pdf",
        "canonical_id": null
      },
      "DOI": "10.1038/s41467-025-66109-9",
      "title": "Mid-gestational cell-type-specific transcriptomic signatures in the prefrontal and superior temporal cortex in Down syndrome",
      "container-title": "Nature Communications",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            11
          ]
        ]
      },
      "author": [
        {
          "family": "Niu",
          "given": "Rui-Ze"
        },
        {
          "family": "Xue",
          "given": "Lu-Lu"
        },
        {
          "family": "Tian",
          "given": "Xiao-He"
        },
        {
          "family": "Huangfu",
          "given": "Li-Ren"
        },
        {
          "family": "Chen",
          "given": "Li"
        },
        {
          "family": "Zhai",
          "given": "Chen-Yang"
        },
        {
          "family": "Wang",
          "given": "Shi-Feng"
        },
        {
          "family": "Zhao",
          "given": "Yang-Yang"
        },
        {
          "family": "Gan",
          "given": "Zong-Jin"
        },
        {
          "family": "Qin",
          "given": "Hao-Yue"
        },
        {
          "family": "Wang",
          "given": "Ting-Hua"
        },
        {
          "family": "Liu",
          "given": "Cheng"
        },
        {
          "family": "Xiong",
          "given": "Liu-Lin"
        }
      ]
    },
    "6": {
      "id": "6",
      "URL": "https://www.nature.com/articles/s42003-025-09028-1",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s42003-025-09028-1",
        "canonical_id": null
      },
      "DOI": "10.1038/s42003-025-09028-1",
      "title": "Platelets regulate neural and oligodendroglial progenitors when infiltrating the brain parenchyma",
      "container-title": "Communications Biology",
      "issued": {
        "date-parts": [
          [
            2025,
            11,
            24
          ]
        ]
      },
      "author": [
        {
          "family": "Dimitriou",
          "given": "Christina"
        },
        {
          "family": "Anesti",
          "given": "Maria"
        },
        {
          "family": "Kaplanis",
          "given": "Stefanos"
        },
        {
          "family": "Mourtzi",
          "given": "Theodora"
        },
        {
          "family": "Dimopoulou",
          "given": "Aggeliki"
        },
        {
          "family": "Dimitrakopoulos",
          "given": "Dimitrios"
        },
        {
          "family": "Katsaitis",
          "given": "Filippos"
        },
        {
          "family": "Nousia",
          "given": "Maria"
        },
        {
          "family": "Mastori",
          "given": "Konstantina"
        },
        {
          "family": "Karassavidou",
          "given": "Kyriaki"
        },
        {
          "family": "Aleiferi",
          "given": "Efthimia"
        },
        {
          "family": "Lagogiannis",
          "given": "Dimitrios"
        },
        {
          "family": "Tahir",
          "given": "Esra"
        },
        {
          "family": "Philp",
          "given": "Amber R."
        },
        {
          "family": "Kouvela",
          "given": "Adamantia"
        },
        {
          "family": "Stathopoulos",
          "given": "Constantinos"
        },
        {
          "family": "Karagogeos",
          "given": "Domna"
        },
        {
          "family": "Franklin",
          "given": "Robin J. M."
        },
        {
          "family": "Ghevaert",
          "given": "Cedric"
        },
        {
          "family": "Rivera",
          "given": "Francisco J."
        },
        {
          "family": "Kazanis",
          "given": "Ilias"
        }
      ],
      "volume": "8",
      "issue": "1"
    },
    "7": {
      "id": "7",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/8502",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/8502",
        "canonical_id": null
      }
    },
    "8": {
      "id": "8",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/20674",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/20674",
        "canonical_id": null
      }
    },
    "9": {
      "id": "9",
      "URL": "https://www.nature.com/articles/s41593-025-02100-3",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41593-025-02100-3",
        "canonical_id": null
      },
      "DOI": "10.1038/s41593-025-02100-3",
      "title": "Distinct transcriptomic and epigenomic responses of mature oligodendrocytes during disease progression in a mouse model of multiple sclerosis",
      "container-title": "Nature Neuroscience",
      "issued": {
        "date-parts": [
          [
            2025,
            11,
            17
          ]
        ]
      },
      "author": [
        {
          "family": "Zheng",
          "given": "Chao"
        },
        {
          "family": "Hervé",
          "given": "Bastien"
        },
        {
          "family": "Meijer",
          "given": "Mandy"
        },
        {
          "family": "Rubio",
          "given": "Rodríguez-Kirby Leslie Ann"
        },
        {
          "family": "Guerreiro",
          "given": "Cacais André Ortlieb"
        },
        {
          "family": "Kukanja",
          "given": "Petra"
        },
        {
          "family": "Kabbe",
          "given": "Mukund"
        },
        {
          "family": "Jimenez-Beristain",
          "given": "Tony"
        },
        {
          "family": "Olsson",
          "given": "Tomas"
        },
        {
          "family": "Agirre",
          "given": "Eneritz"
        },
        {
          "family": "Castelo-Branco",
          "given": "Gonçalo"
        }
      ],
      "volume": "28",
      "issue": "12",
      "pages": "2612-2627"
    },
    "10": {
      "id": "10",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/5318",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/5318",
        "canonical_id": null
      }
    },
    "11": {
      "id": "11",
      "URL": "https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=18508",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=18508",
        "canonical_id": null
      }
    },
    "12": {
      "id": "12",
      "URL": "https://www.science.org/doi/10.1126/sciadv.adw7972",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.science.org/doi/10.1126/sciadv.adw7972",
        "canonical_id": null
      },
      "DOI": "10.1126/sciadv.adw7972",
      "title": "EphB1-NR2B receptor signaling in glutamatergic neurons of the ventroposteromedial thalamic nucleus regulates emergence from anesthesia",
      "container-title": "Science Advances",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            5
          ]
        ]
      },
      "author": [
        {
          "family": "Liu",
          "given": "Yuexin"
        },
        {
          "family": "Hu",
          "given": "Jiang-Jian"
        },
        {
          "family": "Cao",
          "given": "Boxu"
        },
        {
          "family": "Chen",
          "given": "Peng"
        },
        {
          "family": "Peng",
          "given": "Bo"
        },
        {
          "family": "Yao",
          "given": "Hongyu"
        },
        {
          "family": "Song",
          "given": "Xue-Jun"
        }
      ],
      "volume": "11",
      "issue": "49"
    },
    "13": {
      "id": "13",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/121021",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/121021",
        "canonical_id": null
      }
    },
    "14": {
      "id": "14",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/13641",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/13641",
        "canonical_id": null
      }
    },
    "15": {
      "id": "15",
      "URL": "https://www.nature.com/articles/s42003-025-09138-w",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s42003-025-09138-w",
        "canonical_id": null
      },
      "DOI": "10.1038/s42003-025-09138-w",
      "title": "Astrocyte activation persists one year after TBI: a dynamic shift from inflammation to neurodegeneration",
      "container-title": "Communications Biology",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            4
          ]
        ]
      },
      "author": [
        {
          "family": "Abou-El-Hassan",
          "given": "Hadi"
        },
        {
          "family": "Yahya",
          "given": "Taha"
        },
        {
          "family": "Zusman",
          "given": "Benjamin E."
        },
        {
          "family": "Albastaki",
          "given": "Omar"
        },
        {
          "family": "Imkamp",
          "given": "Harm T."
        },
        {
          "family": "Ye",
          "given": "Jessica J."
        },
        {
          "family": "Percopo",
          "given": "Francesca"
        },
        {
          "family": "Christenson",
          "given": "Jonathan R."
        },
        {
          "family": "Al",
          "given": "Mansi Maryam H."
        },
        {
          "family": "Lu",
          "given": "Kuan-Jung"
        },
        {
          "family": "Gabriely",
          "given": "Galina"
        },
        {
          "family": "Tatematsu",
          "given": "Bruna K."
        },
        {
          "family": "Habashy",
          "given": "Karl J."
        },
        {
          "family": "Lopes",
          "given": "Juliana R."
        },
        {
          "family": "Maghzi",
          "given": "Amir-Hadi"
        },
        {
          "family": "Rezende",
          "given": "Rafael M."
        },
        {
          "family": "Quintana",
          "given": "Francisco J."
        },
        {
          "family": "Weiner",
          "given": "Howard L."
        },
        {
          "family": "Izzy",
          "given": "Saef"
        }
      ],
      "volume": "8",
      "issue": "1"
    },
    "16": {
      "id": "16",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/10215",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/10215",
        "canonical_id": null
      }
    },
    "17": {
      "id": "17",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/7422",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/7422",
        "canonical_id": null
      }
    },
    "18": {
      "id": "18",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/2260",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/2260",
        "canonical_id": null
      }
    },
    "19": {
      "id": "19",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/4613",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/4613",
        "canonical_id": null
      }
    },
    "20": {
      "id": "20",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/4804",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/4804",
        "canonical_id": null
      }
    },
    "21": {
      "id": "21",
      "URL": "https://www.nature.com/articles/s41421-025-00842-9",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41421-025-00842-9",
        "canonical_id": null
      },
      "DOI": "10.1038/s41421-025-00842-9",
      "title": "scCirclehunter delineates ecDNA-containing cells using single-cell ATAC-seq, with a focus on glioblastoma",
      "container-title": "Cell Discovery",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            9
          ]
        ]
      },
      "author": [
        {
          "family": "Jiang",
          "given": "Rong"
        },
        {
          "family": "Lu",
          "given": "Zhengmao"
        },
        {
          "family": "Li",
          "given": "Fang"
        },
        {
          "family": "Zhu",
          "given": "Yibei"
        },
        {
          "family": "Yang",
          "given": "Manqiu"
        },
        {
          "family": "Zhang",
          "given": "Shufan"
        },
        {
          "family": "Wu",
          "given": "Ping"
        },
        {
          "family": "Gong",
          "given": "Chengliang"
        },
        {
          "family": "Fei",
          "given": "Yiyuan"
        },
        {
          "family": "Sang",
          "given": "Yonghua"
        },
        {
          "family": "Huang",
          "given": "Yulun"
        },
        {
          "family": "Guo",
          "given": "Jiong Jiong"
        },
        {
          "family": "Huang",
          "given": "Moli"
        }
      ],
      "volume": "11",
      "issue": "1"
    },
    "22": {
      "id": "22",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/7015",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/7015",
        "canonical_id": null
      }
    },
    "23": {
      "id": "23",
      "URL": "https://www.nature.com/articles/s41593-025-02150-7",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41593-025-02150-7",
        "canonical_id": null
      },
      "DOI": "10.1038/s41593-025-02150-7",
      "title": "Single-cell spatiotemporal transcriptomic and chromatin accessibility profiling in developing postnatal human and macaque prefrontal cortex",
      "container-title": "Nature Neuroscience",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            11
          ]
        ]
      },
      "author": [
        {
          "family": "Zhang",
          "given": "Jiyao"
        },
        {
          "family": "Li",
          "given": "Mayuqing"
        },
        {
          "family": "Wang",
          "given": "Mengdi"
        },
        {
          "family": "Sun",
          "given": "Yu"
        },
        {
          "family": "Yin",
          "given": "Chonghai"
        },
        {
          "family": "Yang",
          "given": "Shaotong"
        },
        {
          "family": "Wang",
          "given": "Bosong"
        },
        {
          "family": "Liu",
          "given": "Zeyuan"
        },
        {
          "family": "Wang",
          "given": "Wei"
        },
        {
          "family": "Liu",
          "given": "Min"
        },
        {
          "family": "Zhao",
          "given": "Yuqing"
        },
        {
          "family": "Zhou",
          "given": "Xin"
        },
        {
          "family": "Cai",
          "given": "Lixin"
        },
        {
          "family": "Zhong",
          "given": "Suijuan"
        },
        {
          "family": "Wang",
          "given": "Xiaoqun"
        },
        {
          "family": "Wu",
          "given": "Qian"
        }
      ]
    },
    "24": {
      "id": "24",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/21898",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/21898",
        "canonical_id": null
      }
    },
    "25": {
      "id": "25",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/12053",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/12053",
        "canonical_id": null
      }
    },
    "26": {
      "id": "26",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/18033",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/18033",
        "canonical_id": null
      }
    },
    "27": {
      "id": "27",
      "URL": "https://www.nature.com/articles/s41467-025-66985-1",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41467-025-66985-1",
        "canonical_id": null
      },
      "DOI": "10.1038/s41467-025-66985-1",
      "title": "Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma",
      "container-title": "Nature Communications",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            4
          ]
        ]
      },
      "author": [
        {
          "family": "Braun",
          "given": "Sebastian"
        },
        {
          "family": "Bolivar",
          "given": "Paulina"
        },
        {
          "family": "Oudenaarden",
          "given": "Clara"
        },
        {
          "family": "Sjölund",
          "given": "Jonas"
        },
        {
          "family": "Bocci",
          "given": "Matteo"
        },
        {
          "family": "Harbst",
          "given": "Katja"
        },
        {
          "family": "Talkhoncheh",
          "given": "Mehrnaz Safaee"
        },
        {
          "family": "Phung",
          "given": "Bengt"
        },
        {
          "family": "Cordero",
          "given": "Eugenia"
        },
        {
          "family": "Rosberg",
          "given": "Rebecca"
        },
        {
          "family": "Johansson",
          "given": "Elinn"
        },
        {
          "family": "Jönsson",
          "given": "Göran B."
        },
        {
          "family": "Pietras",
          "given": "Alexander"
        },
        {
          "family": "Pietras",
          "given": "Kristian"
        }
      ],
      "volume": "16",
      "issue": "1"
    },
    "28": {
      "id": "28",
      "URL": "https://www.nature.com/articles/s41598-025-27335-9",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41598-025-27335-9",
        "canonical_id": null
      },
      "DOI": "10.1038/s41598-025-27335-9",
      "title": "Inflammatory transcriptomic signatures in a human cellular NMOSD model reveal upregulation of NF-κB and IL6 pathways",
      "container-title": "Scientific Reports",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            8
          ]
        ]
      },
      "author": [
        {
          "family": "Brandl",
          "given": "Sarah"
        },
        {
          "family": "Yu",
          "given": "Qian"
        },
        {
          "family": "Hagenbuchner",
          "given": "Judith"
        },
        {
          "family": "Endmayr",
          "given": "Verena"
        },
        {
          "family": "Höftberger",
          "given": "Romana"
        },
        {
          "family": "Bradl",
          "given": "Monika"
        },
        {
          "family": "Reindl",
          "given": "Markus"
        }
      ],
      "volume": "15",
      "issue": "1"
    },
    "29": {
      "id": "29",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/6622",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/6622",
        "canonical_id": null
      }
    },
    "30": {
      "id": "30",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/5894",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/5894",
        "canonical_id": null
      }
    },
    "31": {
      "id": "31",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/2670",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/2670",
        "canonical_id": null
      }
    },
    "32": {
      "id": "32",
      "URL": "http://json-schema.org/draft-07/schema#\",",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "http://json-schema.org/draft-07/schema#\",",
        "canonical_id": null
      }
    }
  },
  "compact_bibliography": {
    "entries": [
      "1. Ghazale H, Parga PM, Jung S, Cao K, Vasan L, Hickmott JW, et al.. MicroRNA-mediated neuronal detargeting alters astrocyte cell fate conversion trajectories in vivo. Communications Biology [Internet]. 2025Dec5;8(1). Available from: https://www.nature.com/articles/s42003-025-09169-3",
      "2. Keane S, Sjöberg I, Deland L, Lindlöf A, Bontell TO, Kling T, et al.. Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion. npj Precision Oncology [Internet]. 2025Dec2;9(1). Available from: https://www.nature.com/articles/s41698-025-01190-3",
      "3. Available from: https://www.ncbi.nlm.nih.gov/gene/18015",
      "4. Available from: https://www.ncbi.nlm.nih.gov/gene/546",
      "5. Niu R-Z, Xue L-L, Tian X-H, Huangfu L-R, Chen L, Zhai C-Y, et al.. Mid-gestational cell-type-specific transcriptomic signatures in the prefrontal and superior temporal cortex in Down syndrome. Nature Communications [Internet]. 2025Dec11;. Available from: https://www.nature.com/articles/s41467-025-66109-9_reference.pdf",
      "6. Dimitriou C, Anesti M, Kaplanis S, Mourtzi T, Dimopoulou A, Dimitrakopoulos D, et al.. Platelets regulate neural and oligodendroglial progenitors when infiltrating the brain parenchyma. Communications Biology [Internet]. 2025Nov24;8(1). Available from: https://www.nature.com/articles/s42003-025-09028-1",
      "7. Available from: https://www.ncbi.nlm.nih.gov/gene/8502",
      "8. Available from: https://www.ncbi.nlm.nih.gov/gene/20674",
      "9. Zheng C, Hervé B, Meijer M, Rubio R-KLA, Guerreiro CAO, Kukanja P, et al.. Distinct transcriptomic and epigenomic responses of mature oligodendrocytes during disease progression in a mouse model of multiple sclerosis. Nature Neuroscience [Internet]. 2025Nov17;28(12). Available from: https://www.nature.com/articles/s41593-025-02100-3",
      "10. Available from: https://www.ncbi.nlm.nih.gov/gene/5318",
      "11. Available from: https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=18508",
      "12. Liu Y, Hu J-J, Cao B, Chen P, Peng B, Yao H, et al.. EphB1-NR2B receptor signaling in glutamatergic neurons of the ventroposteromedial thalamic nucleus regulates emergence from anesthesia. Science Advances [Internet]. 2025Dec5;11(49). Available from: https://www.science.org/doi/10.1126/sciadv.adw7972",
      "13. Available from: https://www.ncbi.nlm.nih.gov/gene/121021",
      "14. Available from: https://www.ncbi.nlm.nih.gov/gene/13641",
      "15. Abou-El-Hassan H, Yahya T, Zusman BE, Albastaki O, Imkamp HT, Ye JJ, et al.. Astrocyte activation persists one year after TBI: a dynamic shift from inflammation to neurodegeneration. Communications Biology [Internet]. 2025Dec4;8(1). Available from: https://www.nature.com/articles/s42003-025-09138-w",
      "16. Available from: https://www.ncbi.nlm.nih.gov/gene/10215",
      "17. Available from: https://www.ncbi.nlm.nih.gov/gene/7422",
      "18. Available from: https://www.ncbi.nlm.nih.gov/gene/2260",
      "19. Available from: https://www.ncbi.nlm.nih.gov/gene/4613",
      "20. Available from: https://www.ncbi.nlm.nih.gov/gene/4804",
      "21. Jiang R, Lu Z, Li F, Zhu Y, Yang M, Zhang S, et al.. scCirclehunter delineates ecDNA-containing cells using single-cell ATAC-seq, with a focus on glioblastoma. Cell Discovery [Internet]. 2025Dec9;11(1). Available from: https://www.nature.com/articles/s41421-025-00842-9",
      "22. Available from: https://www.ncbi.nlm.nih.gov/gene/7015",
      "23. Zhang J, Li M, Wang M, Sun Y, Yin C, Yang S, et al.. Single-cell spatiotemporal transcriptomic and chromatin accessibility profiling in developing postnatal human and macaque prefrontal cortex. Nature Neuroscience [Internet]. 2025Dec11;. Available from: https://www.nature.com/articles/s41593-025-02150-7",
      "24. Available from: https://www.ncbi.nlm.nih.gov/gene/21898",
      "25. Available from: https://www.ncbi.nlm.nih.gov/gene/12053",
      "26. Available from: https://www.ncbi.nlm.nih.gov/gene/18033",
      "27. Braun S, Bolivar P, Oudenaarden C, Sjölund J, Bocci M, Harbst K, et al.. Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma. Nature Communications [Internet]. 2025Dec4;16(1). Available from: https://www.nature.com/articles/s41467-025-66985-1",
      "28. Brandl S, Yu Q, Hagenbuchner J, Endmayr V, Höftberger R, Bradl M, et al.. Inflammatory transcriptomic signatures in a human cellular NMOSD model reveal upregulation of NF-κB and IL6 pathways. Scientific Reports [Internet]. 2025Dec8;15(1). Available from: https://www.nature.com/articles/s41598-025-27335-9",
      "29. Available from: https://www.ncbi.nlm.nih.gov/gene/6622",
      "30. Available from: https://www.ncbi.nlm.nih.gov/gene/5894",
      "31. Available from: https://www.ncbi.nlm.nih.gov/gene/2670",
      "32. Available from: http://json-schema.org/draft-07/schema#\","
    ],
    "style": "vancouver",
    "locale": "en-US",
    "renderer": "citeproc",
    "error": null
  },
  "bibliography_stats": {
    "total": 32,
    "resolved": 11,
    "unresolved": 21,
    "methods": {
      "url_pattern": 11,
      "auto_metadata_lookup": 11
    },
    "average_confidence": 0.98
  },
  "unresolved": [
    "3",
    "4",
    "7",
    "8",
    "10",
    "11",
    "13",
    "14",
    "16",
    "17",
    "18",
    "19",
    "20",
    "22",
    "24",
    "25",
    "26",
    "29",
    "30",
    "31",
    "32"
  ]
}